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Indole-containing structures and their generation still draw much attention 
because of their ubiquity in natural products, medicinal compounds, and organic 
materials.  Given this prevalence, synthetic methods toward these structural motifs are 
numerous, each with a distinct set of advantages and disadvantages.  One significant 
challenge is the generation of 3,3-disubstituted indolines that are frequently encountered 
in indole cores.  The discovery, optimization, and scope of a C3-quaternary indolenine 
synthesis, as well as, efforts to expand the methodology for the generation of higher 
order indole-containing polycycles, will be discussed.  This novel reactivity also lead to 
a generalized synthesis of α,β-unsaturated N-aryl ketonitrones which has few literature 
examples.  A modest start to realizing the success of 3-substituted non-N-protected 
indoles as a Michael donor will also be explored. 
Green chemistry continues to play an important role in creating a sustainable 
world.  At the core of green chemistry is the reduction or elimination of the use or 
generation of hazardous substances.  Catalysis by definition is green by reduction; 
however, many of the catalytic systems utilize toxic metals that can hamper or cause 
further concerns with allowable limits on industrial scales.  Iron catalyzed reactions seek 
to replace these toxic metals with a benign one that is also relatively cheap.  Nitrogen 
containing compounds are an important feed stock for the pharmaceutical and other 
industries.  The iron catalyzed intermolecular hydroamination of alkenes with 
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DCM Dichloromethane, methylene chloride 
DMF N,N’-Dimethylformamide 
EDTA Ethylenediaminetetraacetic acid 
Et Ethyl 
i-Pr iso-Propyl 
LG Leaving group 
M Metal atom 
mCPBA meta-chloroperbenzoic acid 
Me Methyl 
MVK Methyl vinyl ketone 





PG Protecting group 
Ph Phenyl 
R Any alkyl, aryl, vinyl, or alkynyl group 
t-Bu tert-Butyl 
Tf Trifluoromethanesulfonyl 
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
TLC Thin layer chromatography 
Ts Tosyl 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Indoles 
 Over 10,000 natural and unnatural indole derivatives have been discovered to 
date.1  Many of these indole derivatives were isolated from natural sources in the animal, 
fungal, microbial, and plant kingdoms.2  The indole core is present in indolenine, 
indoline, oxindole, spiroindoline, pyrroloindoline, furoindoline, carbazole, α-carboline, 
β-carboline, etc. (Figure 1.1).  Due to their biological activity and other 
properties, it is of little surprise that many indole derivatives have found application 
within the pharmaceutical, agricultural, dye, essential oil, and perfume industries.  More 
than 200 natural and unnatural indole derivatives are currently in clinical use or under 
clinical development.1  For example, these indole cores may be found within  
 
 




prescription and over-the-counter drugs and dietary supplements.3  Entire classes of 
drugs exist, such as triptans for migraine sufferers, based on tryptamine, an indole core.  
They are also found in common dietary supplements such as tryptophan, serotonin, and 
melatonin.  Many agricultural pesticides, herbicides, and fungicides, as well as auxins 
used by horticulturalists, contain this moiety.  It is also found in the most common dye 
for blue jeans, indigo; the core may be found in dyes that cover the visible region.  Many 
indole compounds are highly odiferous and found within essential oils and perfumes.  
This prevalence in commercial applications demonstrates the rich functional diversity 
offered by these compounds. 
 With the high prevalence of the indole cores and their unique biological activity, 
synthesis and derivatization is of the utmost importance.  The vast quantity and variation 
in synthetic approaches validate the importance of these molecules and also 
demonstrates the synthetic challenges involved.4  Each synthesis has its own set of 
advantages and disadvantages.  For example, common advantages may include high 
yield, selectivity, ease of purification, etc. while common disadvantages may relate to 
substrate scope and synthetic difficulty of making the starting material.  See Scheme 1.1 
for a generalized approach for indole synthesis.  This schematic is based on Sundberg’s 
1996 book5 and as such does not show approximately the last twenty years of 
innovation.  It does succeed in demonstrating the vast number of synthetic routes. 
 Existing methods to synthesize C3-quaternary indole cores typically rely on C3 
substituted indoles or oxindoles as the starting material,6 thus are typically limited by the 


































Scheme 1.2 Example indolenine synthesis 
 
substituted indoles remain a significant challenge.7  A further challenge exists in the 
generation of indolenines due to their high propensity for rearrangement.  
 Current methods for synthesis of indolenines mainly fall into three categories, 
basic conditions, Fischer’s indole synthesis, and palladium catalysis (Scheme 1.2).  
Under basic conditions, low yields and rearrangement products typically result.8  Upon 
using a Grignard reagent to form the magnesium amide with a 3-substituted indole 
followed by alkylation with an alkyl halide, low yields of the indolenine prevail.  
Treatment with potassium tert-butoxide of 3-substituted indole with a tethered leaving 
group attached forms the spiro-indolenine; however, these indolenines are typically 
 5 
 
unstable and readily migrate to form the rearrangement product.  Under certain 
circumstances, the Fischer’s indole synthesis will produce indolenines (Scheme 1.2, B).9  
Typically, the Fischer’s indole synthesis forces rearrangement products due to the high 
temperatures and strong acid conditions.  If the substrates are chosen that have a low 
propensity for migration such as those in Scheme 1.2 B, the indolenine may survive.  
More recently, palladium catalyzed allylic alkylation of 3-substituted indoles has been 
developed (Scheme 1.2, C).  In 2005, Tamaru succeeded in utilizing allyl alcohols in this 
 
 
Scheme 1.3 Recent advances by Yang group in indolenine chemistry 
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palladium catalyzed transformation10 and in 2006 Trost succeeded in an enantioselective 
variant by changing the ligand.11  Allyl methyl carbonate was used by Rawal in his 
catalytic transformation in 2008.12 
 Recently our group has tackled a few of these challenges.  Similar to the 
magnesium amide in Scheme 1.2, Yang changed the Grignard reagent to an inorganic 
base and triethyl borane to form the N-indolyltriethylborate and achieved typical yields 
in a range between 80% and 95% (Scheme 1.3, A).13  With a few methods developed to 
form indolenines, Yang also sought to generate the C3-stereocenter asymmetrically 
through a catalytic enantioconvergent decarboxylative allylic alkylation of allyl 
indolenine-3-carboxylates (Scheme 1.3, B).14 
 
1.2 Green chemistry and iron catalysis 
 Green chemistry in the most simplified definition is pollution prevention.  
Pollution can be anything from toxins to wasted energy and/or materials.  The ACS 
Green Chemistry Institute® lists and describes the “12 Principles of Green Chemistry” 
as follows:  
1. Prevention:  It is better to prevent waste than to treat or clean up waste after it 
has been created. 
2. Atom Economy:  Synthetic methods should be designed to maximize the 
incorporation of all materials used in the process into the final product. 
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3. Less Hazardous Chemical Syntheses:  Wherever practicable, synthetic methods 
should be designed to use and generate substances that possess little or no 
toxicity to human health and the environment. 
4. Designing Safer Chemicals:  Chemical products should be designed to affect 
their desired function while minimizing their toxicity.  
5. Safer Solvents and Auxiliaries:  The use of auxiliary substances (e.g., solvents, 
separation agents, etc.) should be made unnecessary wherever possible and 
innocuous when used. 
6. Design for Energy Efficiency:  Energy requirements of chemical processes 
should be recognized for their environmental and economic impacts and should 
be minimized.  If possible, synthetic methods should be conducted at ambient 
temperature and pressure. 
7. Use of Renewable Feedstocks:  A raw material of feedstock should be 
renewable rather than depleting whenever technically and economically 
practicable. 
8. Reduce Derivatives:  Unnecessary derivatization (use of blocking groups, 
protection/deprotection, temporary modification of physical/chemical processes) 
should be minimized or avoided if possible, because such steps required addional 
reagents and can generate waste. 




10. Design for Degradation:  Chemical products should be designed so that at the 
end of their function they break down into innocuous degradation products and 
do not persist in the environment. 
11. Real-time analysis for Pollution Prevention:  Analytical methodologies need to 
be further developed to allow for real-time, in-process monitoring and control 
prior to the formation of hazardous substances. 
12. Inherently Safer Chemistry for Accident Prevention:  Substances and the 
form of a substance used in a chemical process should be chosen to minimize the 
potential for chemical accidents, including releases, explosion, and fires. 15 
Though these principles are listed by ACS as a way to prevent pollution in more of an 
altruistic manner without regard to politics but an emphasis on bettering the 
environment, the reality is that money speaks louder than words, and green chemistry is 
cheap chemistry.  Any business model would see that using less is going to save money, 
and virtually every principle saves money for the company.  Where exceptions exist, 
laws make the costs comparable.  For example, Europe has, or at least has begun to, pass 
laws requiring manufacturers to be responsible for the end of life of products.  Though 
the United States does not currently have any laws regarding this Extended Producer 
Responsibility (EPR), states can and are passing laws.16  This means that if disposal is 
expensive they are being taxed more, thus making it more profitable to design the 
products with end of life in mind. 
 Iron catalysis fits into this model for more reasons than just being a catalyst and 
as such has experienced significant growth in recent decades.17  Compared with other 
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heavy or rare metals, iron and many of its salts have low toxicity.  Iron is also one of the 
most abundant metals on earth.  This makes it one of the most inexpensive and 
environmentally friendly choices.  Many of the iron salts and complexes are 
commercially available or easily prepared.  An additional feature of many of the iron-
catalyzed reactions is complementary reactivities and selectivities to other transition 
metal catalysis. 
 Though the pioneering work of iron catalysis began in the 1940’s,18 in the 1970’s 
iron catalysis did not gain the popularity that palladium and nickel found that has 
virtually led their dominance in catalytic systems ever since.19  In the early 1990’s, 
pollution laws were being passed in the United States and by the end of the decade green 
chemistry was being promoted.  Coinciding with this green chemistry push, alternative 
catalysts were investigated and groups such as Fürstner, Cahiez, and Nakamura helped 








2.1 Indolenine synthesis 
 While optimizing γ-oxidation of esters, Yang group discovered the formation of 
the α,β-unsaturated N-phenyl ketonitrone 2.3 from PhNO by changing the solvent 
(Scheme 2.1).21  Efforts to optimize and expand the scope of this nitrone synthesis met 
significant challenges and low yields resulting in efforts to trap 2.3 in situ with alkyne  
 
 
Scheme 2.1 Discovery and crystal structure of 2.6a 
                                                 
* Adapted with permission from Huehls, C. B.; Hood, T. S.; Yang, J. Angew. Chem. Int. Ed.  2012, 51, 
5110; Copyright 2012 John Wiley & Sons, Inc. and Hood, T. S.; Huehls, C. B.; Yang, J. Tetrahedron Lett. 
2012, 53, 4679; Copyright 2012 Elsevier. 
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2.4 and form 2.5, a method to quantify unstable nitrone formation.  Interestingly, 
formation of 2.6a resulted.22  The formation of the indolenine prompted the investigation 
into the possible synthetic utility of this transformation as a means to C3 quaternary 







Entry Solvent Additive[a] T[oC] 2.6a[b] 
1 CH2Cl2 - RT 64 
2 THF - RT 48 
3 ether - RT 21 
4 DMF - RT trace 
5 i-PrOH - RT trace 
6 toluene - RT 68 
            7[c] toluene HOAc RT 7 
            8[c,d] toluene HOAc/H2O RT 45 
9 toluene TFA RT trace 
10 toluene TfOH RT 15 
11 toluene ZnCl2 RT trace 
12 toluene SnCl4 RT trace 
13 toluene FeCl3 RT trace 
14 toluene TiCl4 RT trace 
15 toluene - 40 73 
16 toluene - 80 79 
All reactions were carried out using 1 equiv of 2.3a and 3 equiv of 2.4.  [a] Unless noted 
otherwise, 1.2 equiv of the additive was used.  [b] Yield of the isolated product.  [c] 0.2 
equiv of HOAc was used.  [d] The reaction was carried out in a mixture of toluene/H2O 
(10:1). 
Table 2.1 Optimization of conditions for formation of 2.6a 
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 Various reaction parameters were examined in an attempt to improve reaction 
efficiency (Table 2.1).  The reaction was found to give better yields in non-polar 
solvents (CH2Cl2 or toluene; Table 2.1, entries 1-6).  The addition of both Brønsted and 
Lewis acids decreased the reaction efficiency or shut down the reaction completely 
(Table 2.1, entries 7-14).  Elevated temperature (40 to 80 oC) not only accelerated the 
reaction, but led to improved yields as well (Table 2.1, entries15 and 16).  Thus, all 
subsequent reactions were carried out in toluene at 80 oC unless noted otherwise. 
 
2.3 Scope 
 The scope of the reaction was investigated under the optimized reaction 
conditions using a range of α,β-unsaturated N-phenyl ketonitrones 2.3 and activated 
alkynes (Scheme 2.2).  The yields of 2.6 were affected by the size of the alkyl ester 
groups of both the ketonitrones and the activated alkynes, but in opposite ways.   Higher 
yields were achieved when the ketonitrone with a bulky tert-butyl carboxylate 
substituent was used (2.6a versus 2.6b and 2.6c), however, a lower yield was observed 
when an alkyne with an ester of increased steric bulk was used (2.6e versus 2.6c and 
2.6d).  The α’-alkyl (R2) substituent of the α,β-unsaturated ketonitrones only exerted a 
slight influence over the reaction efficiency (2.6f and 2.6g). 
 Excellent regioselectivity was observed when alkyl propiolates (R4 = H) were 
used.  Only the C3-quaternary indolenines (2.6h, 2.6i, and 2.6j) were formed upon 
reaction of 2.3a with unsymmetrical monoactivated alkynes.  The steric characteristics 
of the ester groups of these monoactivated alkynes had a more pronounced effect over 
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the reaction yields than that of the ester groups of symmetrical activated alkynes.  For 
example, 2.3a with methyl propiolate led to formation of 2.6h in 61% yield whereas 2.6j 
was obtained in only 32% yield from the reaction of 2.3a and tert-butyl propiolate.  A 
C3-quaternary indolenine 2.6k was also formed when the monoactivated alkyne ethyl 3- 
 
 
All reactions were carried out using 1 equivalent of 2.7 and 3 equivalents of activated 
alkynes at 80 oC in toluene until the reaction was complete by TLC analysis (8 – 12 h).  
The yields are of the isolated products. 
 
Scheme 2.2 Reaction of 2.3 and activated alkynes to form 2.6 
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phenylpropiolate was used.  Alkynes without activating groups (such as 6-dodecyne, 
phenylacetylene, and diphenylacetylene; not shown) did not participate in the reaction. 
 
 
All reactions were carried out using 1 equivalent of 2.7 and 3 equivalents of activated 
alkynes at 80 oC in toluene until the reaction was complete by TLC analysis (8 – 12 h).  
The yields are of the isolated products.  [a] These reactions were conducted at RT. 
 
Scheme 2.3 Reaction of 2.7 and activated alkynes to form 2.8 
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 To further explore the generality of this method a series of N-aryl ketonitrones 
without β substituents (2.7) were also investigated (Scheme 2.3).23  Good to moderate 
yields were obtained for reactions of α,β-unsaturated N-tolyl ketonitrones with diethyl 
acetylenedicarboxylate 2.4: the 6-methyl indolenine 2.8i was regioselectively generated 
from the N-meta-tolyl ketonitrone and 5- and 7-methyl indolenines 2.8b and 2.8g were 
formed from the N-para-tolyl and N-ortho-tolyl ketonitrones, respectively.  α,β-
Unsaturated ketonitrones with 2’-bromo, 3’-chloro, and 4’-chloro-N-phenyl groups 
reacted to give indolenines 2.8h, 2.8j, and 2.8c regioselectively.  Substitution of the N-
phenyl group with electron-donating methoxy, dimethylamino, and dimethoxy groups 
was found to be compatible with this reaction (2.8d, 2.8e, and 2.8k).  A significantly 
reduced yield was observed when the N-phenyl ring was substituted with the electron-
withdrawing cyano group 2.8f.  Monoactivated terminal alkynes in the form of methyl, 
ethyl, allyl, and benzyl esters of propiolic acid readily reacted with the α,β-unsaturated 
N-4’-anisyl ketonitrone to give C3-quaternary indolenines 2.8l – 2.8o.  A preliminary 
study showed that the alkyne with a keto activating group rather than an ester was also 
compatible with the reaction (2.8p). 
 To further demonstrate the usefulness and potential synthetic application of these 
C3-quaternary indolenines, simple manipulations were performed.  For example, the 
indolenine moiety of 2.8l could be oxidized with mCPBA to form oxindole 2.9 (Scheme 
2.4).24  Also, reduction of 2.8l with the Hantzsch ester gave 2.10 in 76% yield.25  
Complex mixtures were formed when other reducing agents such as NaBH4, NaBH3CN, 
and NaBH(OAc)3/HOAc were used.  The 3-substitued indole 2.11 was quantitatively 
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formed by the retro-Michael cleavage of one of the C3-substituents when 2.8m was 
treated with pyrrolidine.  This method provides a unique entry to substituted indoles by 
reaction of α,β-unsaturated N-aryl ketonitrones and activated alkynes. 
 
 
Hantzsch ester = diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate. 
 
Scheme 2.4  Some transformations of 2.8l and 2.8m 
 
2.4 Proposed mechanism 
 The formation of 2.6 may initiate with the [5+2] cyclization of 2.3a and 2.12 to 
generate the seven-membered heterocycle 2.14 (Scheme 2.5).26  This may proceed 
through a stepwise process initiated by a nucleophilic Michael attack of the oxygen atom 








accompanied by significant reduction of the energy barrier for C=N double bond 
isomerization to give (Z)-2.13, which cyclizes to form 2.14.  Hydrolysis of 2.14 forms 
2.15.  Further transformations of 2.15 via the [3,3]-sigmatropic rearrangement, 
tautomerization, and intramolecular condensation lead to formation of the C3-quaternary 
indolenine 2.6.28  Only catalytic amount of water is necessary for the entire process since 
it is regenerated upon formation of 2.6.  Alternatively, the [3,3]-sigmatropic 
rearrangement may precede the hydrolysis as shown in Scheme 2.5. 
 Such a mechanism is consistent with the stereoselective formation of the 
diastereomer illustrated for 2.6.  Specifically, minimization of the 1,3-allylic strain 
requires 2.15 to adopt the conformation shown.29  When 2.3 contained an ester group, 
complete stereoselectivity for the anti diastereomer was observed.  This strain directs the 
[3,3]-sigmatropic rearrangement to occur from the sterically less hindered β face to give 
2.6 stereoselectively.  Since the nucleophilic attack of the oxygen atom of the nitrone 
will occur at the β position of the activated alkyne, this mechanism also rationalizes the 
regioselectivity in formation of C3-quaternary indolenines when mono-activated alkynes 
are used. 
 
2.5 Nitrone synthesis 
 With the seemingly broad scope and reactivity of the discovered indolenine 





Entry R Yield 
1 t-Bu 2.3a (64%) 
2 Me 2.3b (8%) 
3 Et 2.3c (11%) 
Table 2.2 Nitrone synthesis with PhNO 
 
the scope of nitrone 2.3 formation under these conditions failed (Table 2.2).  Though the 
tert-butyl ester 2.3a was synthesized in good yield, 2.3b and 2.3c (the methyl and ethyl 
ester) presented challenges. Formation of 2.3b resulted in an 8% yield with similar 
disappointing results for 2.3c (Table 2.2, entries 1 and 2).  Condensation of ethyl 4-
oxopent-2-enoate with phenylhydroxylamine to form 2.3c failed to occur.  Nitrones 2.7 
without β substituents were readily prepared, this approach contains limitations in part 
due to the use of Grignard reagents.23  A fairly robust, general approach was needed to 
synthesize this virtually unused class of α,β-unsaturated nitrones.30 
 A number of nitrone preparations exist,31 but the most convenient and commonly 
used consists of condensing N-monosubstituted hydroxylamines and carbonyl 
compounds or oxidation of the corresponding hydroxylamine, imine, or amine.32  The 
reaction of N-substituted hydroxylamines and aldehydes typically proceeds to give 
aldonitrones in high yield.  Excluding intramolecular variations, the condensation of N-
substituted hydroxylamines and ketones typically requires harsh conditions and is of 




Scheme 2.6 Modular approach to α,β-unsaturated nitrones 
 
unsaturated ketones have been reported,33 our efforts to condense N-aryl hydroxylamines 
and α,β-unsaturated ketones have been unsuccessful.  Thus subsequent efforts focused 
on developing an approach based on oxidation of N-allyl anilines that could be formed 
by condensation of anilines with α,β-unsaturated aldehydes to form N-allylideneanilines 
that could further be alkylated utilizing organometallic reagents (Scheme 2.6).   
 The condensation of anilines and α,β-unsaturated aldehydes was carried out at 
room temperature in ether with MgSO4 as a dehydrating agent.
34  Although all the 
anilines tested condensed with one equivalent of cinnamaldehyde efficiently, a slight 
excess of cinnamaldehyde (1.2 equiv.) produced optimal yields and purity.  Due to the 
instability of the N-allylideneanilines, only filtration and concentration of the reaction in 
vacuo were performed prior to subsequent reactions.  Relatively high yields were 
obtained for alkylation of these non-enolizable imines with alkyl and phenyl lithium 
reagents to give N-allyl anilines 2.19 that were relatively pure based on crude 1H NMR 





















































































Table 2.3  Results for imine formation and following alkylation 
 
Figueredo formed the α,β-unsaturated nitrones 2.20.36  This modular approach allowed 
synthesis of α,β-unsaturated N-aryl ketonitrones with diverse substitution patterns 
(Scheme 2.7). 
 This modular approach allowed for preparations of the ketonitrone substituted by 




Yields of isolated product and ratios given as E:Z.  [a] Yields and ratios estimated from 
crude 1H NMR spectra. 
 
Scheme 2.7 Oxidation of 2.19 to form 2.20 
 
(2.20d) were all easily installed.  The N-aryl group was also easily modified with such 
substituents as 2’-methyl (2.20e), 4’-methyl (2.20f), 4’-chloro (2.20g).  The α- and β-
positions of the α,β- unsaturated N-aryl ketonitrones accepted substitution as well (2.20j, 
2.20k, and 2.20l).  The ketonitrones formed demonstrated a degree of stability.  Most 
could be purified by column chromatography with minimal decomposition over silica 
gel.  However, ketonitrones 2.20j, 2.20k, and 2.20l showed extensive decomposition 
over silica gel. 
 While the C=C double bonds of 2.20 appeared to be generated in the E- geometry 
when relevant, the C=N double bonds formed as E,Z- mixtures in a range of ratios.  
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Determination of the C=N double bond geometry was straightforward when the α’-
substituent was a methyl since Bartoli had established that the geometry is correlated 
with the 1H NMR chemical shift of the methyl group.23  A chemical shift of 2.25-2.31 
ppm associates with a C=N double bond in the E- configuration while a chemical shift of 
1.76-1.91 ppm associates with the Z- double bond geometry.  This also allowed the 
geometries of ketonitrones with α’-ethyl- and butyl-groups to be similarly assigned.  
Ketonitrone 2.20d with a phenyl group at the α’-position formed mainly one 
diastereomer.   When R4 = alkyl, the two vinyl protons of the α,β-unsaturation showed a 
large chemical difference in the Z-isomer (Δδ = 1.0-1.5 ppm) while a smaller chemical 
shift difference (Δδ < 0.5 ppm) was observed for the E-isomer.  A chemical shift 









 Many natural products contain the indole core within larger polycyclic structures.  
Significant challenges exist in the generation of these natural products.  Due to the high 
number of bioactive compounds that contain the indole core, the desire to perform 
bioassays and test for bioactivity of indole natural products exists.  However, when new 
natural products are discovered the minute quantities obtained typically prevent much of 
the desired testing. 
 Pyrroloindolines and hydrocarbazoles are a few of the typical polycycles 
observed.  Efforts to expand upon the former indolenine synthesis to generate these 
polycycles were investigated by either modifying the starting alkyne or utilizing the 
formed indolenine.  As is often the case with methodology, structure is the basis for 
innovation, and vincorine was targeted.  By slight variations in the synthetic route, 
vincorine could possibly be formed through either the initial formation of the 
pyrroloindoline or the hydrocarbazole (Scheme 3.1). 
 Vincorine is the parent compound of an akuammiline alkaloid subclass.  This 
subclass is characterized by a synthetically challenging cage-like system.  Related 










synthesize this subclass.  Qin group synthesized racemic vincorine in 35 steps.37  Ma 
group improved upon the synthesis with an 18 step synthesis in 64% ee.38  As we set out 
on this investigation, only Qin and Ma had completed total syntheses.  Recently, 
MacMillan has completed a highly enantioselective total synthesis in 9 steps.39 
 We envisioned that either route (Scheme 3.1) could be used to enantioselectively 
synthesize vincorine in approximately 9-11 steps.  In route 1, the chirality would be 
imparted by the use of the amino acid derived acetylenes.  In route 2, we sought to 
develop an enantioselective indolenine formation and a general cyclization procedure. 
 
3.2 Pyrroloindolines 
 In an effort to form the pyrroloindoline, the indolenine synthesis was performed 
with an alkyne of greater complexity.  We envisioned that an appending nitrogen atom 
would attack the indolenine intramolecularly at the imine moiety (Scheme 3.2).  Efforts 
to utilize a keto activated alkyne had been shown to be successful (2.8p) and effort 
began based on the conditions used to obtain 2.8 with amino acid derived alkynes.  
These alkynes 3.3, 3.4, and similar alkynes are known compounds and easily  
 
 




Scheme 3.3 Reaction used for optimization and crystal structure of 3.9a 
 
synthesized from amino acids.40   
 Notable differences from the indolenine synthesis of chapter II exist.  The former 
synthesis utilized 3 equivalencies of acetylene to 1 equivalent of nitrone.  When utilizing 
propiolates and/or keto activating groups, the former synthesis also provided better 
results at room temperature.  Under these conditions, the pyrroloindoline synthesis 
produced low quantities of the desired product 3.9a with nitrone 2.7g and acetylene 3.10 
(11-15%).  However, utilizing 1 equivalent of acetylene and 3 equivalencies of nitrone 
improved the yield and heating to 60 oC consistently increased the yield to 30 – 35%. 
 Efforts to further optimize the reaction included screening of solvents such as 
toluene, dichloromethane, tetrahydrofuran, ether, ethanol, and ethyl acetate.  A range of 
acid and base additives were tested which include acetic acid, pyridinium p-
toluenesulfonate, silica gel, triethyl amine, 1,8-diazabicyclo[5.4.0]undec-7-ene, and 
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cesium carbonate.  Other additives included copper (I) iodide and triethyl borane.  These 
additives typically lowered the yield to approximately 20% but rarely completely shut 
down the reaction.  A range of workup conditions was also applied in effort to optimize 
and increase cyclization to no avail.  It has yet to be determined the underlying 
challenges preventing us from reaching a synthetically useful reaction.  See Appendix D 
for a more complete discussion of the effects of the alkyne on the reaction in this study 
(Scheme 3.4). 
 
Scheme 3.4 Investigation into pyrroloindoline formation 
 
3.3 Hydrocarbazoles 
 Our group efforts to reach vincorine through Scheme 3.1 route 2 were initiated 
by focusing on the two parts needed to form the chiral hydrocarbazole, an asymmetric 
indolenine synthesis and a protocol for cyclization.  The group investigated an 
asymmetric indolenine synthesis through the use of chiral auxiliaries and asymmetric 
catalysis utilizing iminium and H-bond catalysis (not shown); their efforts failed to 
produce any enantioenriched indolenine product.  However, initial efforts in reaching a 





Scheme 3.5 Efforts toward the hydrocarbazole 
 
 Initial efforts focused on forming the enolate or the silyl enol ether of 3.12 from 
the appended 2-butanone fragment (Scheme 3.5); however intramolecular cyclization to 
C2 failed to occur.  Efforts then switched to organocatalysts.  Our previous studies 
showed that pyrrolidine would initiate the retro-Michael reaction and eliminate the 2-
butanone fragment to form the 1H-indole (Scheme 2.4).  This prompted investigation 
into a buffered solution of pyrrolidine and acetic acid in an effort to prevent this side 
reaction pathway from occurring (Table 3.1) resulting in a mixture of the desired 
hydrocarbazole (3.13), the 1H-indole (3.14), and the hydrocarbazole with the aza-
Michael reaction (3.15).  Excess pyrrolidine was necessary to prevent the aza-Michael 
reaction from occurring on the synthesized hydrocarbazole with the retro-Michael 
fragment forming 3.15.  Cyclization was also possible when R2 was not H (Table 3.1, 
entry 2).  Reducing the temperature to 0 oC lowered the ratio of 3.14; however, further 
reduction in temperature caused the ratio to start to increase (Table 3.1, entries 4-7). 
 Proline was also tested in the organocatalyzed cyclization reaction by screening 
solvents (Table 3.2).  All of the reactions resulted in high conversion with approximately 
5% of unreacted recoverable starting material.  The optimized pyrrolidine catalyzed 
cyclization (Table 3.1, entry 5) and the initial screening of solvents with proline (Table 
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Entry AcOH Pyrrolidine T (oC) 3.13 : 3.14 : 3.15 
1 2 equiv
[a]
 0.2 equiv RT 0 : 1 : 1.1 
2 2 equiv
[b]
 0.2 equiv RT 1 : 12.3 : 0 
3 0.4 equiv 0.2 equiv RT 3.13 << 3.14 >> 3.15 
4 8 equiv 4 equiv RT 1 : 3.2 : 0 
5 8 equiv 4 equiv 0 1 : 1.6 : 0 
6 8 equiv 4 equiv -20 1 : 1.7 : 0 
7 8 equiv 4 equiv -75 1: 1.9 : 0 
R1 = Me and R2 = H unless noted.  [a] R1 = H.  [b] R1 = H and R2 = CO2Me. 
 
Table 3.1 Efforts towards the hydrocarbazole core and crystal structure of 3.15 
 
3.2, entry 1) were comparable in yield and selectivity.  With several chiral proline 
derived organocatalysts available, these results suggest that the enantioenriched 
hydrocarbazole may be obtained by resolution of the racemic indolenine.  However, this 
line of research was not explored further due to the relatively low overall efficiency of 
the process. 
 
Entry Solvent AcOH Proline T (oC) 3.14 : 3.15 : 3.15 
1 MeOH - 1 equiv RT 1 : 1.6 : 0 
2 DCM 1 equiv 1 equiv RT 1 : 2.0 : 0.6 
3 Tolune 1 equiv 1 equiv RT 1 : 2.7 : 1.1 




EFFORTS TOWARD 3-SUBSTITUTED INDOLE MICHAEL REACTIONS 
 
4.1 Background 
 Conjugate additions of indole to Michael acceptors are relatively well studied 
under various reaction conditions.41  These transformations typically lead to C3-
alkylations to generate C3-mono-alkylated indoles.  Enantioselective variants exist when 
a chiral center is generated in these reactions.  Challenges remain for the alkylation of 
C3-substituted indoles to form the 3,3-disubstituted indoline or indolenine.  Part of the 
challenge is the reversibility of the reaction.  Efforts to perform this transformation 
usually include the trapping of the initially formed indolenine.  This may be done by 
formation of the pyrroloindoline or the furoindoline by an appending N- or O- 
nucleophilic group.  A few groups, including those of MacMillan, You, and Reisman, 
have demonstrated some success.   
 MacMillan utilized organocatalysis to enantioselectively add α,β-unsaturated 
aldehydes to tryptamine or tryptophol derivatives (Figure 4.1, a).42  You activated 3-
acryloyloxazolidin-2-one with the Lewis acid scandium triflate (Figure 4.1, b)43 or used 
a chiral primary amine to catalyze the enantioselective reaction with methyl vinyl ketone 
(MVK) (Figure 4.1, c).44  Reisman utilized a Lewis acid catalyzed reaction with 
amidoacrylates to form pyrroloindolines (Figure 4.1, d).45  Interestingly, only You 
(Figure 4.1, c) attempted to perform the reaction without an N-alkyl group attached.  In 
his efforts, he was unable to prevent the aza-Michael reaction with MVK.   
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Figure 4.1 Reported Michael reactions with 3-substituted indoles 
 
 Interestingly, early efforts to alkylate non-C3 substituted indoles with Michael 
acceptors started by using N1 alkylated indoles similar to the examples in Figure 4.2.  
Efforts in this research sought to initially perform the Michael reaction without cyclizing 
to the pyrroloindoline and without alkylated N1, but the need to cyclize to affect the 
reaction did prove necessary. 
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4.2 3-Substituted indole Michael reaction 
 Building upon our group’s recent advancement of C3-substituted indole 
alkylation with alkyl halides using N-indolyltriethylborates (Scheme 1.3, A),13 efforts to 
alkylate skatole with the Michael acceptor MVK were initiated.  Unfortunately, under 
similar conditions the N-indolyltriethylborate and the MVK failed to react.  After 
replacing the Michael acceptor with β-nitrostyrene, the reaction still failed to occur 
(trace aza-Michael product was observed).  This Michael acceptor allowed for activation 
of the nitro group with copper (II) triflate and a bisoxazoline (BOX) ligand, which led to 
C2 alkylation in trace quantity with low conversion of the starting indole.  In an effort to 
prevent C2 alkylation, skatole was replaced with 2,3,4,9-tetrahydro-1H-carbazole 4.1,  
 
 
Scheme 4.1 Initial efforts to form the Michael adduct 
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and resulted in 60% yield of the desired C3 alkylated product to the aza-Michael product 
in a 2:1 ratio (Scheme 4.1, A).  This result was not reproducible; subsequent reactions 
typically resulted in trace aza-Michael and recovered 4.1.  This suggested that the 
product’s stability may be an issue.  To overcome this challenge, tryptamine was utilized 
to cyclize the initial indolenine into the pyrroloindoline (Scheme 4.1, B).  Again, low 
conversion resulted. 
 Efforts to investigate Michael acceptors amenable to Lewis acid activation were 
further investigated along with different tryptamine derivatives (Figure 4.2).  With 
Michael acceptors 4.4–4.8, the starting tryptamine derivative 4.12 was recovered.  
Approximately 50% conversion occurred when 4.9, 4.10, or 4.11 reacted with the tosyl 
protected tryptamine derivative 4.12 producing the desired pyrroloindolines in 40-50%  
 
 




Acceptor  Yield 
4.9 R = H, R’ = H 43% 
4.10 R = Me, R’ = H 50% 
4.11 R = H, R = CO2Et 50% 
60-70%[a] 
Activated with KOt-Bu/Et3B and Cu(OTf)2 unless noted.  [a] activated with 
SnCl4/BINOL 
Scheme 4.2 Michael reactions 
 
yields (Scheme 4.2).  When Boc, CO2Me, or Ac was utilized as the protecting group, the 
reaction failed to occur and the starting tryptamine derivative 4.12 was recovered.  
Unfortunately, no enantiomeric excess (ee) was observed with 4.9.  Michael acceptor 
4.10 was then tested to limit the conformations and hopefully induce ee.  Again, no ee 
was observed.  In a further effort to induce asymmetry, Michael acceptor 4.11 was 
utilized.  A dr of 2.4:1 was observed without any ee for the pyrrololoindoline.   
 In an effort to increase the conversion and induce asymmetry, Reisman’s 
conditions (Figure 4.1, d) were adapted for use with tosyl protected tryptamine and 4.11.  
Gratifyingly, the reaction proceeded to completion (Scheme 4.2).  However, a 
considerable amount of C2 alkylated product formed that was inseparable from the 
desired product.  Furthermore, on the chiral column of the HPLC, there was overlap with 
the product.  The dr and ee was determined as best as possible for comparison with the 
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previously described method.  For these conditions an approximate dr of 1.9:1 was 
observed with 76% ee for the more abundant isomer. 
 
4.3 Conclusions 
 Consistent reproducible results were not obtainable until the Michael donor was 
switched to the N-tosyl tryptamine derivative 4.12.  Furthermore, both methods, [KOt-
Bu/Et3B and Cu(OTf)2/BOX] and [SnCl4/BINOL], allowed the reaction to proceed with  
 
  
KOt-Bu/Et3B and Cu(OTf)2/BOX SnCl4/BINOL 
 Approximately 50% conversion 
 Trace aza-Michael reaction 
 Isolatable 40-50% yields 
 dr =  2.4:1 
 No ee 
 Complete conversion 
 No aza-Michael reaction 
 Inseparable 60-70% product 
 dr 1.9:1 
 One diastereomer 76% ee 
 Approximately 30% C2-alkylation 
Figure 4.3 Side by side comparison of reaction results 
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varying degrees of success (Figure 4.3).  Activation with KOt-Bu/Et3B and 
Cu(OTf)2/BOX allowed for isolatable product in 40-50% yield to be obtained with a 
2.4:1 dr and no ee; approximately 50% conversion occurred with trace aza-Michael 
alkylation.  While complete conversion and no aza-Michael reaction occurred with 
SnCl4/BINOL, the product was inseparable from the C2 alkylation product.  A higher 






IRON CATALYZED HYDROAMINATION 
5.1 Background 
 Amines constitute an important class of organic compounds because of their 
ubiquity as bulk chemicals, specialty chemicals, materials, and pharmaceuticals.46  Most 
classical approaches to their generation require refined starting material and generate 
byproducts (Figure 5.1, A).  Furthermore, selectivity is an issue  (Figure 5.1, B).  For 
 
 
Figure 5.1 Classical approaches to amines 
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example, substituted amines may be formed by the nucleophilic displacement of alkyl 
halides with amines.  Each newly formed primary, secondary, and tertiary amine is still 
nucleophilic and may perform the same attack on the starting material giving a mixture 
of amine products. 
 Transition metal-catalyzed hydroamination of unactivated alkenes represents an 
effective approach to amines that allows substituted amines to be prepared from readily 
available alkenes.47  Eliminating the need to functionalize the alkene prior to the amine 
formation saves time, material, and money all while reducing the generated waste.  
Typical transition metal-catalyzed hydroamination involves the addition of H-NR2 
across the double bond.  Development of alternative routes to aminate alkenes is 
desirable due to the potential of complementary reactivities, selectivities, and 
efficiencies of these new methods.   
 In the past few years, electrophilic amination reagents such as N-chloroamines 
and hydroxylamine-O-esters have emerged as versatile tools for synthesis of substituted 
amines.48  In connection with our group’s interests in low-valent iron-catalyzed 
functionalization of unactivated alkenes,49 the umpolung reactivity of electrophilic 
 
 




nitrogen reagents was investigated in this iron-catalyzed formal electrophilic amination 
of alkenes (Scheme 5.1).   
 
5.2 Reaction development  
 Investigation commenced with the screening of iron-ligand systems for 
electrophilic hydroamination of styrene 5.1a with O-benzoyl-N-hydroxypiperidine 5.2a 
to form 5.3a.  Initial results were disappointing as only a small amount of product 5.3a 
formed when a solution of 5.1a and 5.2a in THF was treated with FeCl2, iminopyridine 
ligands 5.4 or 5.5, and cyclopentylmagnesium bromide.  Speculating that the reducing 
conditions of the reaction could be detrimental to 5.2a, efforts to increase the yield 
included slow addition of 5.2a.  Gratifyingly, the desired product was obtained in 34% 
and 55% yields with iminopyridine ligands 5.4 and 5.5, respectively, when 5.2a was 
added slowly via a syringe pump (Table 5.1, entries 1 and 2).  The regioselectivity of the 
reaction was excellent as none of the isomeric anti-Markovnikov hydroamination 
product was observed. 
 A number of common bidentate and tridentate ligands were screened under 
similar conditions (Table 5.1, entries 3-10) and bis(imino)pyridine (PDI) 5.11 was found 
to be superior giving amine 5.3a in 71% yield.  The desired amine 5.3a was also formed 
when chiral tridentate 5.12 and 5.13 were employed, however with minimal 
enantiomeric excess (Table 5.1, entries 9 and 10).  Testing of different Grignard reagents 
each gave 5.3a but with different efficiencies.  The lowest yield of 11% (Table 5.1, entry 




Entry [M] Ligand RMgX Yield 5.3a (%) 
1 FeCl2 5.4 C5H9MgBr 34 
2 FeCl2 5.5 C5H9MgBr 55 
3 FeCl2 5.6 C5H9MgBr 60 
4 FeCl2 5.7 C5H9MgBr 49 
5 FeCl2 5.8 C5H9MgBr 48 
6 FeCl2 5.9 C5H9MgBr 55 
7 FeCl2 5.10 C5H9MgBr <55 
8 FeCl2 5.11 C5H9MgBr 71 
9 FeCl2 5.12 C5H9MgBr 27 
10 FeCl2 5.13 C5H9MgBr 47 
11 FeCl2 5.11 EtMgBr 51 
12 FeCl2 5.11 i-PrMgBr 64 
13 FeCl2 5.11 t-BuMgCl 11 
14 FeCl3 5.11 C5H9MgBr 40 
15 Fe(OAc)2 5.11 C5H9MgBr 26 
16 Fe(acac)3 5.11 C5H9MgBr 42 
17 CoCl2 5.8 C5H9MgBr 25 
18 NiCl2 5.8 C5H9MgBr 53 
[a] Reactions were carried out with 10 mol % of [M], 10 mol % of ligand, 2.0 equiv. of 
styrene, 4 equiv. of RMgX, and 1.0 equiv. of O-benzoyl-N-hydroxypiperidine. 
 
Table 5.1 Screening of reaction conditions[a] 
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ethylmagnesium bromide (Table 5.1, entry 11) and isopropylmagnesium bromide (Table 
5.1, entry 12), in 51% and 64% respectively.  Cyclopentylmagnesium bromide remained 
the reagent of choice. 
 The desired amine 5.3a was also formed with the use of other ferrous and ferric 
salts under the reaction conditions even though they were not as effective (Table 5.1, 
entries 14-16).  The use of NiCl2 was also found to yield amine 5.3a in comparable yield 




 The scope of the reaction was evaluated using the optimized reaction condition.  
The reaction appeared to be general for amination with the N-benzoyloxy derivative of 
cyclic secondary amines to give the tertiary amine in good yields with exclusive 
Markovnikov selectivity.  For example, reaction of styrene with N-benzoylpyrrolidine 
gave 5.3b in 70% yield while the corresponding azepane and morpholine derivatives 
gave 5.3c and 5.3d in 61% and 52% yields, respectively.  The reaction was not limited to 
cyclic amines as 5.3e was obtained in 80% yield with N-benzoyloxydiethylamine.  
However, when N-benzoyloxydibenzylamine was used, efforts to isolate 5.3f failed, 
possibly due to decomposition of the substrate under the reducing reaction conditions.   
 The reaction was also found to be compatible with styrene derivatives substituted 
with electron-neutral or electron-donating groups.  For example, ortho-, meta-, and para- 
methyl styrene all gave the expected hydroamination product (5.3g-i).  Though the yield 
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for the ortho- substituted substrate 5.3i (49%) was lower than the other two isomers 5.3g 
(66%) and 5.3h (62%) possibly due to steric reasons.  A similar trend was observed with 
methoxy-substituted styrene derivatives.  Good yields were observed for the  
 
 
Figure 5.2 Substrate scope of hydroamination 
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electrophilic hydroamination of meta- and para-methoxy substituted styrene derivatives 
5.3j (55%) and 5.3k (55%); again, a significantly reduced yield (24%) was observed 
when the methoxy group was at the ortho- position, possibly due to the ability of the 
methoxy group to also interfere with the reaction through coordination to the metal 
center of the reaction intermediates.  Halogen substituents appear to be incompatible 
with the reaction.  When 4-chlorostyrene was treated under the reaction conditions, not 
only was the hydroamination observed, but dehalogenation also occurred resulting in 
5.3a instead of 5.3n.  The reaction with aliphatic terminal alkenes was also unsuccessful 
with no observable desired product detected (not shown). 
 
5.4 Proposed mechanism for hydroamination 
 The proposed mechanism of the reaction is shown in Scheme 5.2.  The reaction 
may initiate with the alkylation of FeCl2 with the Grignard reagent to form organoferrate 
A.  Coordination of this intermediate with styrene followed by β-hydride elimination of 
the alkyl group would give iron hydride complex C.  This can then undergo 
hydrometalation with styrene to form D.50  The tertiary amine product may then be 
formed by the reaction of D with the benzoyloxyamine leaving the iron benzoate 
intermediate E.  Reaction of E with the Grignard reagent can then regenerate A and 





Scheme 5.2 Proposed reaction mechanism for hydroamination 
 
5.5 Conclusion 
 In summary, an operationally simple iron-catalyzed formal hydroamination 
reaction has been developed.  The reaction employs electrophilic benzoyloxyamines as 
the source of nitrogen and cyclopentylmagnesium bromide as the reducing agent.  A 
range of styrene derivatives were employed to give the products with good yields and 
excellent Markovnikov regioselectivity.  To the best of our knowledge, this reaction 







6.1 Indole core generation 
 A novel indolenine synthesis was reported from simple starting materials, 
activated alkynes and α,β-unsaturated N-aryl ketonitrones.  The reaction was optimized, 
the scope investigated, and a possible mechanism proposed.  The use of these 
indolenines was then demonstrated by manipulation into other indole cores. 
 This indolenine synthesis led to a generalized approach to generate α,β-
unsaturated N-aryl ketonitrones as only a couple of literature examples previously 
existed to generate such species.  α,β-Unsaturated aldehydes were condensed with 
aniline derivatives in the presence of magnesium sulfate as a drying agent.  Without 
purification, the imine could be alkylated utilizing alkyl lithium reagents to give N-allyl 
anilines.  Oxidation of the N-allyl anilines provided the desired α,β-unsaturated N-aryl 
ketonitrones. 
 Further efforts to utilize the novel reaction pathway and simple starting materials 
of the indolenine synthesis to generate higher order polycycles was investigated, though 
met with limited success.  Pyrroloindolines were synthesized utilizing α,β-unsaturated N-
aryl ketonitrones and alkynes derived from amino acids with a tethered nucleophilic 
nitrogen for intramolecular cyclization with the formed indolenine.  Approximate yields 
of 35% were observed for a range of substrates which, considering the complexity and 
number of steps occurring, was rather gratifying.  Efforts to utilize the formed 
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indolenines and cyclize the appending C3 butanone fragment also met with modest 
success.  Though an asymmetric indolenine synthesis has failed to come to fruition, the 
general organocatalyzed cyclization with proline suggests that an asymmetric cyclization 
may be possible. 
 A modest start to realizing the success of 3-substituted non-N-protected indoles 
as a Michael donor was achieved.  Efforts to block C2 alkylation with Et3B to form the 
N‑indolyltriethylborate were successful and up to 50% of the desired product was 
obtained.  However, conversion of the reaction was also relatively low with 
approximately 50% of the starting indole being recovered.  Switching of the catalytic 
system proved to fully activate the reaction; however, C2 alkylation occurred and was 
inseparable from the desired product, though the approximate yield of the product was 
60-70% and the approximate ee was determined to be 76%. 
 
6.2 Iron catalysis 
 In efforts to expand upon group efforts into iron-catalyzed chemistry an 
operationally simple iron-catalyzed formal hydroamination reaction has been developed 
and described.  The reaction employs electrophilic benzoyloxyamines as the source of 
nitrogen and cyclopentylmagnesium bromide as the reducing agent.  A range of styrene 
derivatives were employed to give the products with good yields and excellent 
Markovnikov regioselectivity.  To the best of our knowledge, this reaction represents the 
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A.1 General Information 
 All moisture sensitive reactions were carried out in flame-dried flasks under 
nitrogen atmosphere.  Solvents were purified by passage through an activated alumina 
based solvent purification system.  All commercial reagents were used as received. 
Reactions, in general, were magnetically stirred and monitored by TLC performed on 
pre-coated glass-backed TLC plates (Silica Gel 60 F254 250μm thickness).  Spots were 
visualized by UV or by staining with ethanolic phosphomolybdic acid solution.  Flash 
column chromatography was performed using 60 Å Silica Gel (Silicycle, 230-400 mesh) 
as the stationary phase.  1H NMR chemical shifts are reported as δ values in ppm relative 
to CDCl3 (7.26), coupling constants (J) are reported in Hertz (Hz), and multiplicity 
follows normal convention.  CDCl3 (77.16) served as an internal standard for 
13C NMR 
spectra.  Chiral HPLC analyses were performed on a Shimadzu Prominence SiL-20A 
UFLC using Daicel Chemical Industries CHIRALPAK® columns (IA, IB, IC, and AD) 
eluting with hexane / iso-propanol mixtures as indicated.  Mass spectra were obtained at 
the Center for Chemical Characterization and Analysis (Texas A&M University). 
A.2 Experimental procedure for Chapter 2 section 3 
A.2.1 Synthesis of α,β-unsaturated N-aryl ketonitrones 
A.2.1.1 Synthesis of α,β-unsaturated N-phenyl ketonitrones 2.3 
 -Unsaturated N-phenyl ketonitrones 2.3 were synthesized according to the 
procedure we previously described.21 
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 A solution of the nitroarene (0.16 M, 1 equiv.) in anhydrous THF was cooled to -
78 oC and treated with a solution of crotylmagnesium chloride (1.6 M in THF, 1.1 
equiv.) dropwise. The mixture was stirred at the same temperature for 15 min before the 
reaction was quenched with aq. NH4Cl and extracted with diethyl ether (3x). The organic 
phase was dried over anhydrous MgSO4, filtered, and the solvent was removed under 
reduced pressure. The crude was purified by silica gel column chromatography (eluted 
with 100% ethyl acetate or 5% methanol in CH2Cl2) to give 2.7. 
A.2.2 Representative procedure for the synthesis of the C3-quaternary indolenines 
 
 A solution of the -unsaturated N-aryl ketonitrone (0.2 M, 1 equiv.) and the 
activated alkyne (3 equiv.) in toluene was stirred at 80 oC until TLC indicated the 
reaction was complete. The homogenous solution was concentrated in vacuo and the 
residue was purified by silica gel column chromatography, eluted with hexanes–ethyl 
acetate, to give the C3-quaternary indolenines. 




Diethyl 3-(1-(tert-butoxy)-1,4-dioxopentan-2-yl)-3H-indole-2,3-dicarboxylate (2.6a). 
Prepared according to the general procedure in 79% yield.  1H NMR (300 MHz, CDCl3) 
δ 7.80 (d, J = 7.7 Hz, 1H), 7.54 – 7.35 (m, 3H), 4.58 – 4.36 (m, 2H), 4.23 (dd, J = 11.0, 
2.6 Hz, 1H), 4.12 (dq, J = 10.8, 7.1 Hz, 1H), 3.95 (dq, J = 10.8, 7.1 Hz, 1H), 3.36 (dd, J 
= 17.5, 2.5 Hz, 1H), 3.13 (dd, J = 17.5, 11.0 Hz, 1H), 2.18 (s, 3H), 1.45 (t, J = 7.1 Hz, 
3H), 1.21 (s, 9H), 1.06 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 206.0, 169.6, 
169.5, 167.9, 161.4, 154.5, 137.0, 130.0, 128.7, 123.9, 123.9, 82.3, 66.8, 62.4, 62.2, 




Diethyl 3-(1-methoxy-1,4-dioxopentan-2-yl)-3H-indole-2,3-dicarboxylate (2.6b). 
Prepared according to the general procedure in 58% yield.  1H NMR (300 MHz, CDCl3) 
δ 7.78 (d, J = 7.7 Hz, 1H), 7.55 – 7.35 (m, 3H), 4.46 (qd, J = 7.1, 1.7 Hz, 2H), 4.32 (dd, 
J = 10.9, 2.5 Hz, 1H), 4.21 – 3.91 (m, 4H), 3.54 (s, 3H), 3.01 (dd, J = 17.4, 11.0 Hz, 
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1H), 2.73 (dd, J = 17.5, 2.5 Hz, 1H), 2.10 (s, 3H), 1.43 (t, J = 7.1 Hz, 3H), 1.10 (t, J = 
7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 205.8, 171.1, 169.2, 167.7, 161.6, 153.9, 
136.8, 130.2, 129.0, 123.9, 123.8, 67.0, 62.5, 62.4, 52.4, 43.6, 40.8, 30.1, 14.3, 13.8. 
HRMS (ESI, m/z): [M]+ calc.: 390.1553; found: 390.1562. 
 
 
Diethyl 3-(1-ethoxy-1,4-dioxopentan-2-yl)-3H-indole-2,3-dicarboxylate (2.6c). 
Prepared according to the general procedure in 61% yield.  1H NMR (300 MHz, CDCl3) 
δ 7.79 (d, J = 7.6 Hz, 1H), 7.57 – 7.38 (m, 3H), 4.53 – 4.40 (m, 2H), 4.33 (dd, J = 10.8, 
2.6 Hz, 1H), 4.23 – 4.07 (m, 2H), 4.07 – 3.89 (m, 2H), 3.05 (dd, J = 17.4, 10.8 Hz, 1H), 
2.83 (dd, J = 17.5, 2.6 Hz, 1H), 2.12 (s, 3H), 1.45 (t, J = 7.1 Hz, 3H), 1.12 (dt, J = 8.4, 
7.1 Hz, 6H); 13C NMR (75 MHz, CDCl3) δ 205.9, 170.6, 169.3, 167.8, 161.6, 154.1, 
136.9, 130.2, 129.0, 124.0, 123.9, 67.1, 62.5, 62.3, 61.6, 43.64, 40.9, 30.1, 14.4, 13.9. 





Dimethyl 3-(1-ethoxy-1,4-dioxopentan-2-yl)-3H-indole-2,3-dicarboxylate (2.6d). 
Prepared according to the general procedure in 57% yield.  1H NMR (300 MHz, CDCl3) 
δ 7.78 (d, J = 7.0 Hz, 1H), 7.56 – 7.37 (m, 3H), 4.32 (dd, J = 10.9, 2.6 Hz, 1H), 4.00 (s, 
3H), 3.62 (s, 3H), 3.03 (dd, J = 17.4, 11.0 Hz, 1H), 2.73 (dd, J = 17.4, 2.5 Hz, 1H), 2.12 
(s, 3H), 1.14 (t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 205.7, 170.5, 168.7, 
168.2, 161.9, 153.8, 136.7, 130.3, 129.2, 124.0, 123.9, 67.0, 61.6, 53.2, 53.2, 43.6, 40.6, 
30.1, 13.8. HRMS (ESI, m/z): [M]+ calc.: 376.1396; found: 376.1407. 
 
 
Di-tert-butyl 3-(1-ethoxy-1,4-dioxopentan-2-yl)-3H-indole-2,3-dicarboxylate (2.6e). 
Prepared according to the general procedure in 42% yield.  1H NMR (300 MHz, CDCl3) 
δ 7.74 (dd, J = 7.2, 1.8 Hz, 1H), 7.47 – 7.31 (m, 3H), 4.27 (dd, J = 11.0, 2.5 Hz, 1H), 
4.00 – 3.78 (m, 2H), 3.33 (dd, J = 17.6, 2.5 Hz, 1H), 3.12 (dd, J = 17.6, 11.0 Hz, 1H), 
2.15 (s, 3H), 1.63 (s, 9H), 1.23 (s, 9H), 1.09 (t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 206.1, 170.9, 170.7, 166.7, 160.1, 154.7, 137.2, 129.7, 128.3, 123.8, 123.4, 






Diethyl 3-(1-ethoxy-1,4-dioxoundecan-2-yl)-3H-indole-2,3-dicarboxylate (2.6f). 
Prepared according to the general procedure in 70% yield.  1H NMR (300MHz, CDCl3) 
δ 7.77 (m, 1H), 7.55-7.35 (m, 3H), 4.55-3.90 (m, 7H), 3.00 (dd, J = 17.1, 10.5 Hz, 1H), 
2.75 (dd, J = 17.4, 2.7 Hz, 1H), 2.35 (m, 2H), 1.44 (t, J = 7.2 Hz, 3H), 1.35-1.17 (m, 
10H), 1.13 (t, J = 6.9 Hz, 3H), 1.10 (t, J = 7.2 Hz, 3H), 0.85 (t, J = 6.9 Hz, 3H); 13C 
NMR (75MHz, CDCl3) δ 208.5, 170.9, 169.6, 168.0, 161.8, 154.2, 137.1, 130.3, 129.2, 
124.1, 102.8 67.4, 62.7, 62.5, 61.8, 43.7, 43.1, 40.2, 32.0, 29.4, 29.3, 23.9, 22.9, 14.5, 




(2.6g). Prepared according to the general procedure in 61% yield.  1H NMR (300 MHz, 
CDCl3) δ 7.81 – 7.75 (m, 1H), 7.52 – 7.34 (m, 3H), 7.29 – 7.10 (m, 5H), 4.53 – 4.40 (m, 
2H), 4.36 (dd, J = 10.8, 2.7 Hz, 1H), 4.19 – 4.06 (m, 2H), 4.06 – 3.90 (m, 2H), 3.02 (dd, 
J = 17.3, 10.8 Hz, 1H), 2.88 – 2.76 (m, 2H), 2.76 – 2.64 (m, 2H), 1.45 (t, J = 7.1 Hz, 
3H), 1.12 (dt, J = 7.7, 7.2 Hz, 6H); 13C NMR (75 MHz, CDCl3) δ 207.1, 170.6, 169.3, 
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167.7, 161.6, 154.0, 141.0, 136.9, 130.2, 129.0, 128.6, 128.6, 128.4, 126.2, 123.9, 123.9, 
67.2, 62.5, 62.3, 61.6, 44.5, 43.6, 40.1, 29.6, 14.4, 13.9. HRMS (ESI, m/z): [M]+ calc.: 
494.2179; found: 494.2169. 
 
 
Methyl 3-(1-(tert-butoxy)-1,4-dioxopentan-2-yl)-3H-indole-3-carboxylate (2.6h). 
Prepared according to the general procedure in 61% yield.  1H NMR (300 MHz, CDCl3) 
δ 8.30 (s, 1H), 7.64 (d, J = 7.7 Hz, 1H), 7.42 (t, J = 7.7 Hz, 2H), 7.28 (t, J = 7.5 Hz, 1H), 
4.11 (dd, J = 8.3, 4.4 Hz, 1H), 3.68 (s, 3H), 2.35 (dd, J = 17.6, 8.3 Hz, 1H), 1.83 (s, 3H), 
1.67 (dd, J = 17.6, 4.4 Hz, 1H), 1.47 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 205.3, 171.2, 
171.1, 169.6, 155.4, 134.5, 129.9, 127.3, 123.7, 121.6, 82.7, 67.9, 53.1, 44.8, 39.5, 30.0, 
28.0. HRMS (ESI, m/z): [M]+ calc.: 346.1654; found: 346.1641. 
 
 
Ethyl 3-(1-(tert-butoxy)-1,4-dioxopentan-2-yl)-3H-indole-3-carboxylate (2.6i). 
Prepared according to the general procedure in 45% yield.  1H NMR (300 MHz, CDCl3) 
δ 8.31 (s, 1H), 7.62 (d, J = 7.6 Hz, 1H), 7.47 – 7.36 (m, 2H), 7.31 – 7.22 (m, 1H), 4.21 – 
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4.02 (m, 3H), 2.34 (dd, J = 17.5, 8.4 Hz, 1H), 1.83 (s, 3H), 1.67 (dd, J = 17.6, 4.4 Hz, 
1H), 1.46 (s, 9H), 1.18 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 205.3, 171.4, 
171.1, 168.9, 155.4, 134.6, 129.8, 127.2, 123.6, 121.6, 82.6, 68.0, 62.2, 44.7, 39.6, 30.0, 
28.0, 14.0. HRMS (ESI, m/z): [M]+ calc.: 360.1811; found: 360.1802. 
 
 
tert-Butyl 3-(1-(tert-butoxy)-1,4-dioxopentan-2-yl)-3H-indole-3-carboxylate (2.6j). 
Prepared according to the general procedure in 32% yield.  1H NMR (300 MHz, CDCl3) 
δ 8.34 (s, 1H), 7.61 (d, J = 7.2 Hz, 1H), 7.44 – 7.35 (m, 2H), 7.30 – 7.21 (m, 1H), 4.02 
(dd, J = 8.3, 4.5 Hz, 1H), 2.32 (dd, J = 17.3, 8.3 Hz, 1H), 1.83 (s, 3H), 1.72 (dd, J = 
17.4, 4.5 Hz, 1H), 1.45 (s, 9H), 1.35 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 205.2, 172.0, 
171.4, 167.7, 155.6, 135.0, 129.6, 127.0, 123.4, 121.5, 83.1, 82.5, 69.1, 44.8, 40.1, 30.0, 




(2.6k). Prepared according to the general procedure in 37% yield. 1H NMR (300 MHz, 
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CDCl3) δ 8.14 – 8.06 (m, 2H), 7.68 (d, J = 7.6 Hz, 1H), 7.51 – 7.40 (m, 5H), 7.31 – 7.23 
(m, 1H), 4.17 – 3.89 (m, 3H), 3.34 (dd, J = 17.5, 3.1 Hz, 1H), 3.16 (dd, J = 17.5, 10.3 
Hz, 1H), 2.19 (s, 3H), 1.01 – 0.92 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 206.3, 170.2, 
169.2, 155.9, 137.6, 133.2, 131.0, 130.3, 129.7, 128.7, 128.6, 126.1, 123.3, 121.5, 81.6, 




(E)-N-(But-3-en-2-ylidene)aniline oxide (2.7a). Prepared according to the general 
procedure in 86% yield.  1H NMR (300 MHz, CDCl3) δ 7.52 – 7.40 (m, 3H), 7.36 – 7.28 
(m, 2H), 6.33 (dd, J = 17.1, 11.1 Hz, 1H), 5.51 (d, J = 17.1 Hz, 1H), 5.23 (d, J = 11.1 
Hz, 1H), 2.40 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 129.9, 129.6, 129.5, 124.4, 123.6, 
118.5, 12.8.  HRMS (ESI, m/z): [M]+ calc.: 162.0919; found: 162.0914. 
 
 
(E)-N-(But-3-en-2-ylidene)-4-methylaniline oxide (2.7b). Prepared according to the 
general procedure in 45% yield.  1H NMR (300 MHz, CDCl3) δ 7.27 – 7.17 (m, 4H), 
6.36 (dd, J = 17.1, 11.1 Hz, 1H), 5.49 (d, J = 17.2 Hz, 1H), 5.21 (d, J = 11.2 Hz, 1H), 
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2.39 (s, 3H), 2.38 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 139.6, 130.0, 130.0, 124.2, 
123.4, 118.1, 21.3, 12.8. HRMS (ESI, m/z): [M]+ calc.: 176.1075; found: 176.1071. 
 
 
(E)-N-(But-3-en-2-ylidene)-4-chloroaniline oxide (2.7c). Prepared according to the 
general procedure in 78% yield. 1H NMR (300 MHz, CDCl3) δ 7.43 (d, J = 8.4 Hz, 2H), 
7.29 (d, J = 8.4 Hz, 2H), 6.33 (dd, J = 17.1, 11.1 Hz, 1H), 5.54 (d, J = 17.1 Hz, 1H), 
5.27 (d, J = 11.1 Hz, 1H), 2.39 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 135.4, 129.7, 




(E)-N-(But-3-en-2-ylidene)-4-methoxyaniline oxide (2.7d). Prepared according to the 
general procedure in 65% yield. 1H NMR (300 MHz, CDCl3) δ 7.27 (d, J = 8.9 Hz, 2H), 
6.93 (d, J = 9.0 Hz, 2H), 6.38 (dd, J = 17.2, 11.1 Hz, 1H), 5.49 (d, J = 17.1 Hz, 1H), 
5.22 (d, J = 11.1 Hz, 1H), 3.83 (s, 3H), 2.38 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 





(E)-N-(But-3-en-2-ylidene)-4-(dimethylamino)aniline oxide (2.7e). Prepared 
according to the general procedure in 56% yield. 1H NMR (300 MHz, CDCl3) δ 7.20 (d, 
J = 9.1 Hz, 2H), 6.67 (d, J = 9.1 Hz, 2H), 6.46 (dd, J = 17.2, 11.1 Hz, 1H), 5.45 (d, J = 
17.2 Hz, 1H), 5.18 (d, J = 11.1 Hz, 1H), 2.99 (s, 6H), 2.37 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 130.6, 125.3, 117.3, 111.8, 40.6, 13.1. HRMS (ESI, m/z): [M]
+ calc.: 
205.1341; found: 205.1333. 
 
 
 (E)-N-(But-3-en-2-ylidene)-4-cyanoaniline oxide (2.7f). Prepared according to the 
general procedure in 20% yield. 1H NMR (300 MHz, CDCl3) δ 7.72 (d, J = 8.6 Hz, 2H), 
7.41 (d, J = 8.5 Hz, 2H), 6.20 (dd, J = 17.0, 11.1 Hz, 1H), 5.56 (d, J = 17.0 Hz, 1H), 
5.29 (d, J = 11.1 Hz, 1H), 2.35 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 133.53, 128.68, 






(E)-N-(But-3-en-2-ylidene)-2-methylaniline oxide (2.7g). Prepared according to the 
general procedure in 70% yield.  1H NMR (300 MHz, CDCl3) δ 7.37 – 7.15 (m, 4H), 
6.15 (dd, J = 17.1, 11.1 Hz, 1H), 5.52 (d, J = 17.1 Hz, 1H), 5.22 (d, J = 11.1 Hz, 1H), 
2.41 (s, 3H), 2.21 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 131.9, 131.5, 129.4, 129.2, 




(E)-2-Bromo-N-(but-3-en-2-ylidene)aniline oxide (2.7h). Prepared according to the 
general procedure in 67% yield. 1H NMR (300 MHz, CDCl3) δ 7.65 (dd, J = 8.0, 1.3 Hz, 
1H), 7.46 – 7.27 (m, 3H), 6.11 (dd, J = 17.0, 11.1 Hz, 1H), 5.57 (d, J = 17.0 Hz, 1H), 
5.28 (d, J = 11.1 Hz, 1H), 2.41 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 133.9, 130.6, 






(E)-N-(But-3-en-2-ylidene)-3-methylaniline oxide (2.7i). Prepared according to the 
general procedure in 70% yield.  1H NMR (300 MHz, CDCl3) δ 7.38 – 7.07 (m, 3H), 
6.35 (dd, J = 17.0, 11.2 Hz, 1H), 5.50 (d, J = 17.1 Hz, 1H), 5.23 (d, J = 11.1 Hz, 1H), 
2.39 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 130.2, 130.0, 129.3, 124.9, 121.4, 118.3, 
21.4, 12.7. HRMS (ESI, m/z): [M]+ calc.: 176.1075; found: 176.1068. 
 
 
(E)-N-(But-3-en-2-ylidene)-3-chloroaniline oxide (2.7j). Prepared according to the 
general procedure in 48% yield. 1H NMR (300 MHz, CDCl3) δ 7.44 – 7.34 (m, 3H), 
7.24 – 7.19 (m, 1H), 6.31 (dd, J = 17.1, 11.1 Hz, 1H), 5.54 (d, J = 17.1 Hz, 1H), 5.28 (d, 
J = 11.1 Hz, 1H), 2.38 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 130.6, 129.8, 129.4, 124.9, 





(E)-N-(But-3-en-2-ylidene)-2,4-dimethoxyaniline oxide (2.7k). Prepared according to 
the general procedure in 71% yield. 1H NMR (300 MHz, CDCl3) δ 7.18 (d, J = 9.5 Hz, 
1H), 6.56 – 6.48 (m, 2H), 6.23 (dd, J = 17.2, 11.1 Hz, 1H), 5.48 (d, J = 17.1 Hz, 1H), 
5.20 (d, J = 11.2 Hz, 1H), 3.83 (s, 3H), 3.80 (s, 3H), 2.38 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 161.4, 153.0, 129.9, 126.4, 118.2, 104.8, 99.7, 56.1, 55.8, 12.4. HRMS ( SI, 
m/z): [M]+ calc.: 222.1130; found: 222.1132. 
 
 
Diethyl 3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (2.8a). Prepared according to the 
general procedure in 70% yield.  1H NMR (300 MHz, CDCl3) δ 7.81 (d, J = 7.6 Hz, 1H), 
7.50 – 7.36 (m, 3H), 4.44 (qd, J = 14.2, 7.1, 1.8 Hz, 2H), 4.14 (ddd, J = 17.9, 9.0, 5.3 
Hz, 1H), 3.95 (dq, J = 14.2, 10.8, 7.1 Hz, 1H), 2.90 – 2.67 (m, 2H), 1.86 (s, 3H), 1.97 – 
1.64 (m, 2H), 1.42 (t, J = 7.1 Hz, 3H), 1.07 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 206.7, 170.0, 168.7, 161.4, 154.0, 138.5, 129.8, 129.2, 123.7, 122.7, 66.6, 






Diethyl 5-methyl-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (2.8b). Prepared 
according to the general procedure in 52% yield.  1H NMR (300 MHz, CDCl3) δ 7.69 (d, 
J = 7.9 Hz, 1H), 7.30 – 7.16 (m, 2H), 4.44 (qd, J = 7.1, 2.2 Hz, 2H), 4.17 (dq, J = 10.8, 
7.1 Hz, 1H), 3.95 (dq, J = 10.7, 7.1 Hz, 1H), 2.90 – 2.65 (m, 2H), 2.42 (s, 3H), 1.97 – 
1.83 (m, 1H), 1.89 (s, 3H), 1.78 – 1.67 (m, 1H), 1.42 (t, J = 7.1 Hz, 3H), 1.09 (t, J = 7.1 
Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 206.9, 169.0, 169.0, 161.6, 151.9, 139.9, 138.7, 
130.6, 123.4, 123.3, 66.3, 62.3, 62.0, 37.2, 30.0, 27.1, 21.9, 14.4, 14.0. HRMS (ESI, 
m/z): [M]+ calc.: 346.1655; found: 346.1653. 
 
 
Diethyl 5-chloro-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (2.8c). Prepared 
according to the general procedure in 57% yield.  1H NMR (300 MHz, CDCl3) δ 7.74 (d, 
J = 8.3 Hz, 1H), 7.49 – 7.37 (m, 2H), 4.45 (dq, J = 14.2, 7.1, 1.6 Hz, 2H), 4.18 (dq, J = 
14.2, 10.8, 7.1 Hz, 1H), 3.98 (dq, J = 14.1, 10.6, 7.0 Hz, 1H), 2.92 – 2.63 (m, 2H), 1.92 
(s, 3H), 1.98 – 1.77 (m, 2H), 1.42 (t, J = 7.1 Hz, 3H), 1.11 (t, J = 7.1 Hz, 3H); 13C NMR 
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(75 MHz, CDCl3) δ 206.4, 168.1, 161.2, 152.5, 140.2, 135.4, 130.2, 124.6, 123.3, 66.9, 




Diethyl 5-methoxy-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate dicarboxylate (2.8d). 
Prepared according to the general procedure in 52% yield.  1H NMR (300 MHz, CDCl3) 
δ 7.72 (d, J = 8.5 Hz, 1H), 7.00 – 6.89 (m, 2H), 4.43 (dq, J = 7.1, 2.3 Hz, 2H), 4.17 (dq, 
J = 10.8, 7.1 Hz, 1H), 3.96 (dq, J = 10.7, 7.1 Hz, 1H), 3.84 (s, 3H), 2.84 (ddd, J = 14.2, 
9.7, 6.1 Hz, 1H), 2.75 – 2.63 (m, 1H), 1.97 – 1.84 (m, 1H), 1.89 (s, 3H), 1.72 (ddd, J = 
17.8, 9.7, 5.3 Hz, 1H), 1.42 (t, J = 7.1 Hz, 3H), 1.09 (t, J = 7.1 Hz, 3H); 13C NMR (75 
MHz, CDCl3) δ 206.8, 168.9, 167.6, 161.5, 161.1, 147.5, 140.6, 124.6, 115.4, 108.3, 
66.5, 62.2, 62.1, 56.0, 37.1, 30.0, 27.3, 14.4, 14.0. HRMS (ESI, m/z): [M]+ calc.: 





Diethyl 5-(dimethylamino)-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (2.8e). 
Prepared according to the general procedure in 53% yield.  1H NMR (300 MHz, CDCl3) 
δ 7.65 (d, J = 8.7 Hz, 1H), 6.71 (dd, J = 8.7, 2.6 Hz, 1H), 6.65 (d, J = 2.5 Hz, 1H), 4.42 
(qd, J = 7.1, 2.7 Hz, 2H), 4.19 (dq, J = 14.2, 10.8, 7.1 Hz, 1H), 3.94 (dq, J = 10.8, 7.1 
Hz, 1H), 3.04 (s, 6H), 2.83 (ddd, J = 14.1, 10.3, 5.8 Hz, 1H), 2.75 – 2.61 (m, 1H), 2.02 – 
1.85 (m, 1H), 1.90 (s, 3H), 1.77 – 1.62 (m, 1H), 1.41 (t, J = 7.1 Hz, 3H), 1.10 (t, J = 7.1 
Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 207.2, 169.6, 164.0, 161.7, 151.4, 143.8, 141.1, 
124.4, 112.4, 105.5, 65.9, 61.8, 61.8, 40.7, 37.1, 30.0, 27.6, 14.4, 14.0. HRMS (ESI, 
m/z): [M]+ calc.: 375.1920; found: 375.1911. 
 
 
Diethyl 5-cyano-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (2.8f). Prepared 
according to the general procedure in 22% yield.  1H NMR (300 MHz, CDCl3) δ 7.92 (d, 
J = 8.0 Hz, 1H), 7.80 (dd, J = 8.1, 1.5 Hz, 1H), 7.71 (d, J = 0.9 Hz, 1H), 4.49 (qd, J = 
7.1, 0.9 Hz, 2H), 4.19 (dq, J = 14.2, 10.8, 7.1 Hz, 1H), 4.01 (dq, J = 14.2, 10.8, 7.1 Hz, 
1H), 2.96 – 2.83 (m, 1H), 2.80 – 2.67 (m, 1H), 1.94 (s, 3H), 1.95 – 1.84 (m, 2H), 1.45 (t, 






Diethyl 7-methyl-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (2.8g). Prepared 
according to the general procedure in 78% yield.  1H NMR (300 MHz, CDCl3) δ 7.34 – 
7.17 (m, 3H), 4.46 (qd, J = 7.1, 0.9 Hz, 2H), 4.15 (dq, J = 10.8, 7.1 Hz, 1H), 3.95 (dq, J 
= 10.8, 7.1 Hz, 1H), 2.89 – 2.68 (m, 2H), 2.67 (s, 1H), 1.89 (s, 1H), 1.96 – 1.82 (m, 1H), 
1.79 – 1.65 (m, 1H), 1.43 (t, J = 7.1 Hz, 3H), 1.09 (t, J = 7.1 Hz, 3H); 13C NMR (75 
MHz, CDCl3) δ 206.9, 169.0, 168.8, 161.6, 152.9, 138.5, 134.0, 131.2, 129.2, 120.0, 
66.7, 62.4, 62.0, 37.2, 30.0, 27.1, 17.2, 14.3, 14.0. HRMS (ESI, m/z): [M]+ calc.: 
346.1655; found: 346.1646. 
 
 
Diethyl 7-bromo-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (2.8h). Prepared 
according to the general procedure in 74% yield.  1H NMR (300 MHz, CDCl3) δ 7.62 
(dd, J = 7.9, 1.1 Hz, 1H), 7.38 – 7.21 (m, 2H), 4.45 (qd, J = 7.1, 1.7 Hz, 2H), 4.15 (dq, J 
= 10.8, 7.1 Hz, 1H), 3.96 (dq, J = 10.8, 7.1 Hz, 1H), 2.92 – 2.64 (m, 2H), 2.02 – 1.85 (m, 
1H), 1.90 (s, 3H), 1.71 (ddd, J = 17.9, 9.7, 5.3 Hz, 1H), 1.42 (t, J = 7.1 Hz, 3H), 1.09 (t, 
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J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 206.5, 170.9, 168.2, 161.3, 152.6, 140.0, 
133.5, 130.4, 121.7, 117.7, 68.3, 62.6, 62.4, 37.0, 30.0, 27.2, 14.3, 13.9. HRMS (ESI, 
m/z): [M]+ calc.: 410.0603; found: 410.0609. 
 
 
Diethyl 6-methyl-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (2.8i). Prepared 
according to the general procedure in 61% yield.  1H NMR (300 MHz, CDCl3) δ 7.62 (s, 
1H), 7.32 – 7.17 (m, 2H), 4.46 (dq, J = 7.1, 1.8 Hz, 2H), 4.15 (dq, J = 14.2, 10.8, 7.1 Hz, 
1H), 3.95 (dq, 1H), 2.88 – 2.66 (m, 2H), 2.44 (s, 3H), 1.89 (s, 3H), 1.97 – 1.82 (m, 1H), 
1.82 – 1.66 (m, 1H), 1.43 (t, J = 7.1 Hz, 3H), 1.09 (t, J = 7.1 Hz, 3H); 13C NMR (75 
MHz, CDCl3) δ 206.8, 170.1, 168.9, 161.4, 154.3, 140.1, 135.5, 130.0, 124.3, 122.2, 
66.2, 62.3, 61.9, 37.11, 29.9, 26.9, 21.7, 14.3, 13.9. HRMS (ESI, m/z): [M]+ calc.: 





Diethyl 6-chloro-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (2.8j). Prepared 
according to the general procedure in 33% yield.  1H NMR (300 MHz, CDCl3) δ 7.80 
(dd, J = 1.8, 0.5 Hz, 1H), 7.42 – 7.31 (m, 2H), 4.47 (qd, 2H), 4.16 (dq, J = 14.2, 10.7, 
7.1 Hz, 1H), 3.98 (dq, J = 10.8, 7.1 Hz, 1H), 2.92 – 2.67 (m, 2H), 1.91 (s, 3H), 1.98 – 
1.75 (m, 2H), 1.44 (t, J = 7.1, 2.5 Hz, 3H), 1.11 (t, 3H); 13C NMR (75 MHz, CDCl3) δ 
206.31, 168.09, 161.05, 160.31, 154.98, 136.62, 135.45, 129.10, 123.90, 123.38, 66.47, 




Diethyl 5,7-dimethoxy-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (2.8k). Prepared 
according to the general procedure in 52% yield.  1H NMR (300 MHz, cdcl3) δ 6.49 (s, 
6H), 4.45 – 4.32 (dq, 2H), 4.22 – 4.08 (dq, 1H), 3.96 (s, 3H), 4.01 – 3.88 (dq, 1H), 3.83 
(s, 3H), 2.82 (ddd, J = 14.3, 10.4, 5.7 Hz, 1H), 2.71 – 2.57 (m, 1H), 1.99 – 1.83 (m, 1H), 
1.90 (s, 3H), 1.75 – 1.60 (m, 1H), 1.37 (td, J = 7.1Hz, 3H), 1.07 (t, J = 7.1Hz, 3H). 





Methyl 5-methoxy-3-(3-oxobutyl)-3H-indole-3-carboxylate (2.8l). Prepared according 
to the general procedure in 66% yield.  1H NMR (300 MHz, CDCl3) δ 7.99 (s, 1H), 7.54 
(d, J = 8.5 Hz, 1H), 7.04 (d, J = 2.5 Hz, 1H), 6.92 (dd, J = 8.5, 2.6 Hz, 1H), 3.84 (s, 3H), 
3.69 (s, 3H), 2.56 (ddd, J = 14.0, 9.3, 6.1 Hz, 1H), 2.46 – 2.32 (m, 1H), 2.21 – 2.01 (m, 
2H), 1.99 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 206.8, 170.1, 169.4, 159.3, 148.9, 
137.8, 122.0, 114.3, 109.8, 66.9, 56.0, 53.1, 37.8, 30.1, 27.7. HRMS (ESI, m/z): [M]+ 
calc.: 276.1236; found: 276.1241. 
 
 
Ethyl 5-methoxy-3-(3-oxobutyl)-3H-indole-3-carboxylate (2.8m). Prepared according 
to the general procedure in 52% yield.  1H NMR (300 MHz, CDCl3) δ 7.99 (s, 1H), 7.51 
(d, J = 8.5 Hz, 1H), 7.03 (d, J = 2.5 Hz, 1H), 6.90 (dd, J = 8.5, 2.6 Hz, 1H), 4.25 – 4.02 
(m, 2H), 3.82 (s, 3H), 2.54 (ddd, J = 14.1, 9.3, 6.1 Hz, 1H), 2.46 – 2.29 (m, 1H), 2.14 – 
2.00 (m, 2H), 1.97 (s, 3H), 1.20 (t, J = 7.1 Hz, 3H);  13C NMR (75 MHz, CDCl3) δ 
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206.7, 169.5, 169.4, 159.1, 148.7, 137.7, 121.7, 114.1, 109.7, 66.8, 62.0, 55.8, 37.6, 
29.9, 27.6, 14.0. HRMS (ESI, m/z): [M]+ calc.: 290.1393; found: 290.1397. 
  
 
Allyl 5-methoxy-3-(3-oxobutyl)-3H-indole-3-carboxylate (2.8n). Prepared according 
to the general procedure in 61% yield.  1H NMR (300 MHz, CDCl3) δ 8.01 (s, 1H), 7.54 
(d, J = 8.5 Hz, 1H), 7.04 (d, J = 2.5 Hz, 1H), 6.92 (dd, J = 8.5, 2.6 Hz, 1H), 5.83 (ddt, J 
= 17.2, 10.4, 5.7 Hz, 1H), 5.30 – 5.16 (m, 2H), 4.67 – 4.49 (m, 2H), 3.84 (s, 3H), 2.58 
(ddd, J = 14.1, 9.4, 6.1 Hz, 1H), 2.49 – 2.32 (m, 1H), 2.15 – 2.01 (m, 2H), 1.98 (s, 3H); 
13C NMR (75 MHz, CDCl3) δ 206.8, 169.3, 169.2, 159.3, 148.9, 137.7, 131.3, 122.0, 
119.0, 114.4, 109.8, 66.9, 66.5, 55.9, 37.7, 30.1, 27.7.  HRMS (ESI, m/z): [M]+ calc.: 
302.1392; found: 302.1386. 
 
 
Benzyl 5-methoxy-3-(3-oxobutyl)-3H-indole-3-carboxylate (2.8o). Prepared 
according to the general procedure in 69% yield.  1H NMR (300 MHz, CDCl3) δ 8.02 (s, 
1H), 7.54 (d, J = 8.5 Hz, 1H), 7.38 – 7.29 (m, 3H), 7.27 – 7.20 (m, 2H), 7.01 (d, J = 2.5 
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Hz, 1H), 6.92 (dd, J = 8.5, 2.6 Hz, 1H), 5.12 (q, J = 12.3 Hz, 2H), 3.81 (s, 3H), 2.56 
(ddd, J = 14.0, 9.4, 6.0 Hz, 1H), 2.47 – 2.31 (m, 1H), 2.12 – 1.99 (m, 2H), 1.95 (s, 3H); 
13C NMR (75 MHz, CDCl3) δ 206.8, 169.3, 159.3, 135.2, 128.7, 128.6, 128.2, 122.0, 




1-(5-methoxy-3-(3-oxobutyl)-3H-indol-3-yl)octan-1-one (2.8p). Prepared according to 
the general procedure in 69% yield.  1H NMR (300 MHz, CDCl3) δ 7.92 (s, 1H), 7.63 (d, 
J = 8.5 Hz, 1H), 6.97 (dd, J = 8.5, 2.5 Hz, 1H), 6.83 (d, J = 2.5 Hz, 1H), 3.83 (s, 3H), 
2.64 – 2.50 (m, 1H), 2.44 – 2.30 (m, 1H), 2.06 – 1.88 (m, 7H), 1.38 (dt, J = 14.3, 7.2 Hz, 
2H), 1.30 – 0.94 (m, 8H), 0.82 (t, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 207.3, 
203.8, 169.5, 159.5, 150.3, 138.4, 122.4, 114.7, 109.0, 75.2, 55.9, 39.4, 37.8, 31.7, 30.1, 








7.2.4 Procedures for synthesis of 2.9, 2.10, and 2.11 
 
Methyl 5-methoxy-2-oxo-3-(3-oxobutyl)indoline-3-carboxylate (2.9).  A mixture of 
2.8l (210 mg, 0.76 mmol) and NaHCO3 (64 mg, 0.76 mmol) in methylene chloride (10 
mL) was treated with mCPBA (70%,  376 mg, 1.53 mmol) and stirred at room 
temperature until the reaction was complete as shown by TLC. The mixture was taken 
into ethyl acetate and washed with aq. NaHSO3, Na2CO3, and brine. The organic phase 
was separated, dried over anhydrous MgSO4, filtered, and concentrated. The residue was 
purified by silica gel column chromatography, eluted with hexanes-ethyl acetate (1:3), to 
give 2.9 (148 mg, 67%) as colorless oil. 1H NMR (300 MHz, CDCl3) δ 9.11 (s, 1H), 
6.97 – 6.67 (m, 3H), 3.76 (s, 3H), 3.69 (s, 3H), 2.59 – 2.23 (m, 4H), 2.04 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 207.3, 176.5, 169.5, 156.3, 134.5, 129.5, 114.3, 111.0, 110.6, 






Methyl 5-methoxy-3-(3-oxobutyl)indoline-3-carboxylate (2.10).  A solution of 2.8l 
(38 mg, 0.14 mmol) and trifluoroacetic acid (27.6 L, 41 mg, 0.36 mmol) in 
dichloromethane (1.5 mL) was treated with the Hantzsch ester (35 mg, 0.14 mmol) and 
stirred in the dark at room temperature overnight. After dilution with diethyl ether, the 
mixture was washed with aq. Na2CO3 and dried over anhydrous MgSO4 before it was 
filtered and concentrated. The residue was purified by silica gel column chromatography 
eluting with hexanes-ethyl acetate (1:3) to give 2.10 (29 mg, 76%) as yellow oil. 1H 
NMR (300 MHz, CDCl3) δ 6.91 (d, J = 2.5 Hz, 1H), 6.68 (dd, J = 8.5, 2.5 Hz, 1H), 6.60 
(d, J = 8.5 Hz, 1H), 4.08 (d, J = 9.9 Hz, 1H), 3.75 (s, 3H), 3.72 (s, 3H), 3.37 (d, J = 9.9 
Hz, 1H), 2.53 – 2.18 (m, 4H), 2.10 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 207.8, 174.1, 
153.8, 144.7, 131.1, 114.5, 111.5, 111.2, 56.2, 56.1, 55.2, 52.6, 39.1, 31.6, 30.1. HRMS 
(ESI, m/z): [M]+ calc.: 278.1392; found: 278.1384. 
 
 
Ethyl 5-methoxy-1H-indole-3-carboxylate (2.11). A solution of 2.8m (50 mg, 0.17 
mmol) in toluene (1 mL) was treated with pyrrolidine (28.9 L, 24.4 mg, 0.34 mmol) 
and stirred at room temperature until the reaction was complete as shown by TLC.  The 
residue was purified by silica gel column chromatography eluting with hexanes-ethyl 
acetate (1:3) to give 2.11 (38.3 mg, quantitative).  1H NMR (300 MHz, CDCl3) δ 8.81 
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(bs, 1H), 7.86 (d, J = 3.1 Hz, 1H), 7.68 (d, J = 2.5 Hz, 1H), 7.29 (dd, J = 8.8, 0.5 Hz, 
1H), 6.94 – 6.88 (m, 1H), 4.39 (q, J = 7.1 Hz, 2H), 3.88 (s, 3H), 1.42 (t, J = 7.1 Hz, 3H).  
13C NMR (75 MHz, CDCl3) δ 165.6, 155.9, 131.4, 131.1, 126.9, 113.7, 112.5, 108.7, 
102.9, 59.9, 55.8, 14.7. 
 
A.2.5 Crystal and molecular structure determination of 2.6a 
X-ray Diffraction Laboratory 
Department of Chemistry 




Table A.1.  Crystal data and structure refinement for 2.6a. 
Empirical formula  C23 H29 N O7 
Formula weight  431.47 
Temperature  110(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 14.1598(11) Å = 90°. 
 b = 9.3637(7) Å = 110.345(4)°. 
 c = 18.1995(18) Å  = 90°. 
Volume 2262.5(3) Å3 
Z 4 
Density (calculated) 1.267 Mg/m3 
Absorption coefficient 0.776 mm-1 
F(000) 920 
Crystal size 0.10 x 0.05 x 0.05 mm3 
Theta range for data collection 3.43 to 59.99°. 
Index ranges -15<=h<=15, -10<=k<=10, -20<=l<=18 
Reflections collected 17097 
Independent reflections 3293 [R(int) = 0.0635] 
Completeness to theta = 59.99° 98.1 %  
Absorption correction None 
Max. and min. transmission 0.9622 and 0.9265 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3293 / 0 / 281 
Goodness-of-fit on F2 1.012 
Final R indices [I>2sigma(I)] R1 = 0.0439, wR2 = 0.1072 
R indices (all data) R1 = 0.0647, wR2 = 0.1224 
Extinction coefficient 0.0035(4) 
Largest diff. peak and hole 0.231 and -0.224 e.Å-3 
 
Table A.2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 




 x y z U(eq) 
________________________________________________________________________________   
O(1) 5586(1) 4984(2) 1197(1) 41(1) 
O(2) 5928(1) 3554(2) 2264(1) 36(1) 
O(3) 6108(1) 1488(2) 726(1) 46(1) 
O(4) 2877(1) 1050(2) 638(1) 45(1) 
O(5) 2099(1) 2371(2) 1289(1) 41(1) 
O(6) 4473(1) 3422(2) 3426(1) 51(1) 
O(7) 4211(1) 1593(2) 2568(1) 43(1) 
N(1) 3456(1) 5140(2) 2089(1) 41(1) 
C(1) 3599(2) 3325(2) 1217(1) 34(1) 
C(2) 3753(2) 3854(2) 2044(1) 36(1) 
C(3) 3043(2) 5657(2) 1307(1) 38(1) 
C(4) 2616(2) 6991(3) 1084(2) 46(1) 
C(5) 2252(2) 7304(3) 289(2) 48(1) 
C(6) 2298(2) 6299(3) -254(2) 46(1) 
C(7) 2718(2) 4962(3) -28(1) 40(1) 
C(8) 3105(2) 4652(2) 763(1) 35(1) 
C(9) 4609(2) 2842(2) 1114(1) 34(1) 
C(10) 5430(2) 3923(2) 1516(1) 35(1) 
C(11) 6715(2) 4506(2) 2792(1) 38(1) 
C(12) 7573(2) 4711(3) 2476(1) 46(1) 
C(13) 7074(2) 3672(3) 3552(1) 47(1) 
C(14) 6241(2) 5904(3) 2899(2) 48(1) 
C(15) 4517(2) 2666(2) 260(1) 34(1) 
C(16) 5386(2) 1864(2) 159(1) 37(1) 
C(17) 5312(2) 1577(3) -663(1) 42(1) 
C(18) 2831(2) 2093(3) 1008(1) 36(1) 
C(19) 1252(2) 1376(3) 1076(1) 46(1) 
C(20) 454(2) 1874(4) 339(2) 70(1) 
C(21) 4190(2) 2976(3) 2765(2) 40(1) 
C(22) 4657(2) 595(3) 3213(2) 54(1) 
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C(23) 4721(2) -804(3) 2870(2) 67(1) 
________________________________________________________________________________  
Table A.3.   Bond lengths [Å] and angles [°] for  2.6a. 
_____________________________________________________  
O(1)-C(10)  1.209(3) 
O(2)-C(10)  1.343(3) 
O(2)-C(11)  1.489(3) 
O(3)-C(16)  1.225(3) 
O(4)-C(18)  1.201(3) 
O(5)-C(18)  1.332(3) 
O(5)-C(19)  1.460(3) 
O(6)-C(21)  1.202(3) 
O(7)-C(21)  1.347(3) 
O(7)-C(22)  1.460(3) 
N(1)-C(2)  1.288(3) 
N(1)-C(3)  1.423(3) 
C(1)-C(8)  1.522(3) 
C(1)-C(2)  1.526(3) 
C(1)-C(18)  1.539(3) 
C(1)-C(9)  1.572(3) 
C(2)-C(21)  1.489(3) 
C(3)-C(4)  1.386(3) 
C(3)-C(8)  1.390(3) 
C(4)-C(5)  1.387(4) 
C(4)-H(4A)  0.9500 
C(5)-C(6)  1.383(4) 
C(5)-H(5A)  0.9500 
C(6)-C(7)  1.386(3) 
C(6)-H(6A)  0.9500 
C(7)-C(8)  1.380(3) 
C(7)-H(7A)  0.9500 
C(9)-C(10)  1.523(3) 
C(9)-C(15)  1.524(3) 
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C(9)-H(9A)  1.0000 
C(11)-C(13)  1.515(3) 
C(11)-C(14)  1.515(3) 
C(11)-C(12)  1.526(3) 
C(12)-H(12A)  0.9800 
C(12)-H(12B)  0.9800 
C(12)-H(12C)  0.9800 
C(13)-H(13A)  0.9800 
C(13)-H(13B)  0.9800 
C(13)-H(13C)  0.9800 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
C(15)-C(16)  1.505(3) 
C(15)-H(15A)  0.9900 
C(15)-H(15B)  0.9900 
C(16)-C(17)  1.488(3) 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
C(19)-C(20)  1.496(4) 
C(19)-H(19A)  0.9900 
C(19)-H(19B)  0.9900 
C(20)-H(20A)  0.9800 
C(20)-H(20B)  0.9800 
C(20)-H(20C)  0.9800 
C(22)-C(23)  1.467(4) 
C(22)-H(22B)  0.9900 
C(22)-H(22C)  0.9900 
C(23)-H(23A)  0.9800 
C(23)-H(23B)  0.9800 




























































































































Table A.4.   Anisotropic displacement parameters  (Å2x 103) for 2.6a.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 37(1)  41(1) 42(1)  5(1) 9(1)  -5(1) 
O(2) 29(1)  38(1) 36(1)  0(1) 6(1)  -1(1) 
O(3) 36(1)  57(1) 45(1)  8(1) 14(1)  11(1) 
O(4) 40(1)  42(1) 53(1)  -8(1) 17(1)  -4(1) 
O(5) 32(1)  44(1) 49(1)  -3(1) 16(1)  -3(1) 
O(6) 53(1)  59(1) 39(1)  -5(1) 14(1)  8(1) 
O(7) 47(1)  40(1) 41(1)  3(1) 15(1)  4(1) 
N(1) 31(1)  44(1) 47(1)  -3(1) 13(1)  2(1) 
C(1) 27(1)  37(1) 38(1)  0(1) 10(1)  2(1) 
C(2) 26(1)  42(1) 41(1)  -2(1) 12(1)  0(1) 
C(3) 26(1)  41(1) 47(2)  1(1) 11(1)  0(1) 
C(4) 32(1)  40(2) 65(2)  -3(1) 16(1)  2(1) 
C(5) 29(1)  44(2) 66(2)  10(1) 10(1)  4(1) 
C(6) 32(1)  48(2) 53(2)  12(1) 10(1)  6(1) 
C(7) 28(1)  47(2) 43(2)  2(1) 10(1)  1(1) 
C(8) 23(1)  38(1) 44(1)  1(1) 11(1)  -1(1) 
C(9) 28(1)  35(1) 40(1)  -1(1) 11(1)  2(1) 
C(10) 28(1)  42(1) 35(1)  0(1) 10(1)  5(1) 
C(11) 30(1)  41(1) 37(1)  -6(1) 6(1)  -5(1) 
C(12) 32(1)  55(2) 48(2)  -4(1) 10(1)  -4(1) 
C(13) 42(2)  50(2) 39(2)  1(1) 3(1)  -4(1) 
C(14) 41(2)  44(2) 54(2)  -10(1) 10(1)  0(1) 
C(15) 28(1)  40(1) 32(1)  -1(1) 8(1)  0(1) 
C(16) 29(1)  38(1) 44(2)  1(1) 13(1)  -4(1) 
C(17) 37(1)  46(1) 44(2)  -1(1) 17(1)  1(1) 
C(18) 27(1)  40(1) 38(1)  2(1) 10(1)  3(1) 
C(19) 33(1)  52(2) 55(2)  -1(1) 18(1)  -9(1) 
C(20) 42(2)  102(3) 56(2)  -10(2) 5(1)  -5(2) 
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C(21) 32(1)  45(2) 45(2)  -2(1) 15(1)  1(1) 
C(22) 61(2)  53(2) 49(2)  13(1) 20(1)  12(1) 
C(23) 73(2)  53(2) 70(2)  10(2) 17(2)  9(2) 
______________________________________________________________________________ 
 
Table A.5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for 2.6a. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(4A) 2574 7666 1461 56 
H(5A) 1968 8216 117 58 
H(6A) 2036 6531 -796 55 
H(7A) 2738 4276 -406 47 
H(9A) 4810 1900 1382 41 
H(12A) 7849 3778 2414 69 
H(12B) 8103 5294 2843 69 
H(12C) 7316 5193 1966 69 
H(13A) 6515 3548 3746 70 
H(13B) 7621 4196 3942 70 
H(13C) 7320 2734 3461 70 
H(14A) 5694 5714 3099 72 
H(14B) 5971 6398 2394 72 
H(14C) 6751 6506 3273 72 
H(15A) 3884 2151 -24 41 
H(15B) 4474 3622 19 41 
H(17A) 5913 1058 -663 62 
H(17B) 5264 2484 -942 62 
H(17C) 4711 1001 -924 62 
H(19A) 974 1322 1505 55 
H(19B) 1484 410 996 55 
H(20A) -115 1207 198 105 
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H(20B) 730 1914 -85 105 
H(20C) 223 2826 423 105 
H(22B) 4234 531 3545 65 
H(22C) 5337 925 3543 65 
H(23A) 5016 -1498 3290 101 
H(23B) 5144 -728 2545 101 




A.3 Experimental procedure for Chapter 2 section 5 
A.3.1 General experimental procedure 
A.3.1.1 Synthesis of imines 2.18 
 A solution of aniline (12.5 mmol) in diethyl ether (30 mL) was treated with 
anhydrous MgSO4 (5.0 g) followed by dropwise addition of the α,β-unsaturated 
aldehyde (12 mmol for cinnamaldehydes and 15 mmol for others).  The suspension was 
stirred at room temperature for 15 h under a nitrogen atmosphere before the solid was 
removed by filtration.  The filtrate was then concentrated under reduced pressure to give 
crude N-allylideneanilines 2.18 that were essentially pure by 1H NMR.  N-
Allylideneanilines 2.18  were used in the next step without purification. 
A.3.1.2 Synthesis of N-allyl anilines 2.19 
 N-allylideneaniline 2.18 (6.50 mmol) was taken into THF and cooled to -78 oC 
before dropwise treatment with an ethereal solution of alkyl or phenyl lithium reagent 
(9.75 mmol).  The mixture was stirred for 20-30 minutes before being quenched with aq. 
NH4Cl.  The aqueous phase was extracted with ethyl acetate (2x).  The combined 
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organic phases were washed with brine, dried over anhydrous Na2SO4, and concentrated.  
The crude was used without further purification 
A.3.1.2 Synthesis of N-aryl ketonitrones 2.20 
 The N-aryl aniline 2.19 (0.26 mmol) was taken into a mixed solvent of THF 
(0.75 mL) and CH3CN (2.9 mL), and 0.01 M aq. Na2EDTA (2.9 mL).  The mixture was 
cooled to 4 oC and treated with NaHCO3 (0.108g, 1.29 mmol).  The mixture was warmed 
to RT and Oxone® (0.437g, 0.71 mmol) was added in portions.  After 20 min, EtOAc 
was added.  The organic layer was separated and the aqueous layer was extracted with 
EtOAc (3x).  The combined organic layers were washed with brine, dried over 
anhydrous Ns2SO4, and concentrated to give the crude nitrone, which was purified by 
silica gel chromatography eluting with dichloromethane-methanol or ethyl acetate-
acetone. 
A.3.2 Spectra data for compounds 
 
 
(E)-N-((E)-3-phenylallylidene)aniline (2.18a) Yield: 77%. Spectral data for this 





(E)-2-methyl-N-((E)-3-phenylallylidene)aniline (2.18e) Yield: 95%. Spectral data for 
this compound were consistent with those found in the literature.52 
 
 
(E)-4-methyl-N-((E)-3-phenylallylidene)aniline (2.18f) Yield: 45%. Spectral data for 
this compound were consistent with those found in the literature.52 
 
 
(E)-4-chloro-N-((E)-3-phenylallylidene)aniline (2.18g) Yield: 65%. Spectral data for 





(E)-N-((E)-3-(4-methoxyphenyl)allylidene)aniline (2.18h) Yield: 75%. Spectral data 
for this compound were consistent with those found in the literature.54 
 
 
(E)-N-((E)-3-(4-methoxyphenyl)allylidene)-2-methylaniline (2.18i). Yield 74%; 1H 
NMR (300MHz, CDCl3) δ 8.12 (dd, J = 7.8, 0.6 Hz, 1H), 7.53-7.47 (m, 2H), 7.24-7.16 
(m, 2H), 7.14-7.09 (m, 1H), 7.09-7.05 (m, 1H), 7.04 (d, J = 7.8 Hz, 1H), 6.96-6.90 (m, 
2H), 6.89-6.84 (m, 1H), 3.85 (s, 3H), 2.34 (s, 3H); 13C NMR (75MHz, CDCl3) δ 161.7, 
160.7, 151.5, 143.4, 131.6, 130.2, 129.0, 128.4, 126.7, 126.6, 125.4, 117.8, 114.3, 55.4, 
17.9.  HRMS (ESI, m/z): [M]+ calc.: 251.1388; found: 252.1396. 
 
 
(E)-3-methoxy-N-(3-methylbut-2-en-1-ylidene)aniline (2.18k). Yield 93%; 1H NMR 
(300MHz, CDCl3) δ 8.37 (d, J = 9.6 Hz, 1H), 7.28-7.21 (m, 1H), 6.78-6.65 (m, 3H), 
6.25-6.18 (m, 1H), 3.82, (s, 3H), 2.02 (m, 3H), 1.97 (d, J = 1.2 Hz, 3H); 13C NMR 
(75MHz, CDCl3) δ 160.6, 159.3, 154.4, 150.9, 130.1, 126.5, 113.2, 111.6, 107.1, 55.6, 





(E)-N-((E)-2-methylbut-2-en-1-ylidene)aniline (2.18l). Yield 91%. 1H NMR 
(300MHz, CDCl3) δ 8.37 (d, J = 9.6 Hz, 1H), 7.40-7.30 (m, 2H), 7.22-7.15 (m, 1H), 
7.14-7.08 (m, 2H), 6.26-6.20 (m, 1H), 2.04-2.00 (m, 3H), 1.99-1.95 (m, 3H); 13C NMR 
(75MHz, CDCl3) δ 159.2, 153.0, 150.6, 129.4, 126.6, 125.8, 121.2, 27.2, 19.3.  HRMS 
(ESI, m/z): [M]+ calc.: 160.1126; found: 160.1121. 
 
 
(E)-N-(4-phenylbut-3-en-2-yl)aniline (2.19a). Yield: Quantitative. Spectral data 
for this compound were consistent with those found in the literature.55 
 
 
(E)-N-(1-phenylpent-1-en-3-yl)aniline (2.19b). Yield 98%; 1H NMR (300MHz, 
CDCl3) δ 7.40-7.13 (m, 7H), 6.72-6.63 (m, 3H), 6.59 (d, J = 15.9 Hz, 1H), 6.14 (dd, J = 
15.9, 6.3 Hz, 1H), 3.94-3.86 (m, 1H), 3.75 (br. s, 1H), 1.80-1.67 (m, 2H), 1.04 (t, J = 7.2 
Hz, 3H); 13C NMR (75MHz, CDCl3) δ 148.0, 137.4, 132.3, 130.7, 128.8, 127.6, 126.7, 
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(E)-N-(1-phenylhept-1-en-3-yl)aniline (2.19c) Yield: 91%. Spectral data for this 
compound were consistent with those found in the literature.56 
 
 
(E)-N-(1,3-diphenylallyl)aniline  (2.19d)  Yield:  Quantitative.  Spectral data for this 
compound were consistent with those found in the literature.57 
 
 
(E)-2-methyl-N-(4-phenylbut-3-en-2-yl)aniline (2.19e). Yield 96%; 1H NMR 
(300MHz, CDCl3) δ 7.40-7.12 (m, 5H), 7.13-7.05 (m, 2H), 6.71-6.62 (m, 2H), 6.59 (dd, 
J = 15.9, 1.2 Hz, 1H), 4.25-4.15 (m, 1H), 3.56 (br. s, 1H), 2.19 (s, 3H), 1.46 (d, J = 6.6 
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Hz, 3H); 13C NMR (75MHz, CDCl3) δ 145.7, 137.3, 133.7, 130.4, 129.6, 128.8, 127.7, 
127.4, 126.7, 122.0, 117.2, 111.2, 51.0, 22.6, 18.0. HRMS (ESI, m/z): [M]+ calc.: 
238.1596; found: 238.1589. 
 
 
(E)-4-methyl-N-(4-phenylbut-3-en-2-yl)aniline (2.19f). Yield 97%; 1H NMR 
(300MHz, CDCl3) δ 7.40-7.16 (m, 5H), 7.01-6.95 (m, 2H), 6.63-6.54 (m, 3H), 6.23 (dd, 
J = 16.2, 6 Hz, 1H), 4.18-4.07 (m, 1H), 3.58 (br. s, 1H), 2.24 (s, 3H), 1.40 (d, J = 6.6 Hz, 
3H); 13C NMR (75MHz, CDCl3) δ 145.4, 137.4, 133.8, 130.0, 129.5, 128.8, 127.6, 




(E)-4-chloro-N-(4-phenylbut-3-en-2-yl)aniline (2.19g). Yield 99%; 1H NMR 
(300MHz, CDCl3) δ 7.38-7.18 (m, 5H), 7.13-7.07 (m, 2H), 6.60-6.51 (m, 3H), 6.18 (dd, 
J = 15.9, 5.7 Hz, 1H), 4.17-4.04 (m, 1H), 3.73 (br. s, 1H), 1.41 (d, J = 6.6 Hz, 3H); 13C 
NMR (75MHz, CDCl3) δ 146.3, 137.1, 132.9, 129.9, 129.3, 128.9, 127.8, 126.7, 122.2, 




(E)-N-(4-(4-methoxyphenyl)but-3-en-2-yl)aniline (2.19h). Yield 98%; 1H NMR 
(300MHz, CDCl3) δ 7.32-7.27 (m, 2H), 7.21-7.13 (m, 2H), 6.88-6.81 (m, 2H), 6.73-6.63 
(m, 3H), 6.52 (d, J = 15.9 Hz, 1H), 6.08 (dd, J = 15.9, 6 Hz, 1H), 4.18-4.08 (m, 1H), 
3.80 (s, 3H), 3.70 (br. s, 1H), 1.40 (d, J = 6.6 Hz, 3H); 13C NMR (75MHz, CDCl3) δ 
159.4, 147.8, 131.3, 130.1, 129.5, 129.0, 127.8, 114.6, 114.3, 113.7, 55.6, 51.2, 22.5. 
HRMS (ESI, m/z): [M]+ calc.: 254.1545; found: 254.1548. 
 
 
(E)-N-(4-(4-methoxyphenyl)but-3-en-2-yl)-2-methylaniline (2.19i). Yield 99%; 1H 
NMR (300MHz, CDCl3) δ 7.33-7.27 (m, 2H), 7.12-7.04(m, 2H), 6.87-6.81 (m, 2H), 
6.71-6.61 (m, 2H), 6.53 (d, J = 15.9 Hz, 1H), 6.11 (dd, J = 15.9, 5.7 Hz, 1H), 4.23-4.13 
(m, 1H), 3.80 (s, 3H), 3.55 (br. s, 1H), 2.18 (s, 3H), 1.44 (d, J = 6.6 Hz, 3H); 13C NMR 
(75MHz, CDCl3) δ 159.4, 145.72, 131.5, 130.1, 129.0, 127.8, 127.4, 122.0, 117.1, 114.2, 





(E)-N-(pent-3-en-2-yl)aniline (2.19j) Yield: 91%. Spectral data for this compound were 
consistent with those found in the literature.58 
 
 
3-methoxy-N-(4-methylpent-3-en-2-yl)aniline (2.19k). Yield 95%; 1H NMR 
(300MHz, CDCl3) δ 7.05 (t, J = 8.1 Hz, 1H), 6.27-6.13 (m, 3H), 5.09-5.03 (m, 1H), 
4.18-4.07 (m, 1H), 3.80-3.77 (m, 1H), 3.76 (s, 3H) 3.62 (br. s, 1H) 1.74 (d, J = 1.5 Hz, 
3H), 1.70 (d, J = 2.4 Hz, 3H), 1.24 (d, J = 6.3 Hz, 3H); 13C NMR (75MHz, CDCl3) δ 
161.0, 149.4, 133.0, 130.1, 129.7, 106.8, 102.6, 99.3, 55.3, 47.6, 26.0, 22.4, 18.5.  
HRMS (ESI, m/z): [M]+ calc.: 206.1545; found: 206.1554. 
  
 
(E)-N-(3-methylpent-3-en-2-yl)aniline (2.19l) Yield: 82%. Spectral data for this 





(Z)-N-((E)-4-phenylbut-3-en-2-ylidene)aniline oxide (Z-2.20a). Yield 80% combined 
isomers; 1H NMR (300MHz, CDCl3) δ 8.05 (d, 1H, J = 16.5 Hz), 7.64-7.59 (m, 2H), 
7.52-7.29 (m, 8H), 7.12 (d, J = 16.8 Hz, 2H), 2.14 (s, 3H); 13C NMR (75MHz, CDCl3) δ 
138.1, 136.5, 129.9, 129.8, 129.7, 129.6, 129.2, 128.0, 128.0, 124.0, 120.8, 16.7.  HRMS 
(ESI, m/z): [M]+ calc.: 238.1232; found: 238.1221. 
 
 
(E)-N-((E)-4-phenylbut-3-en-2-ylidene)aniline oxide (E-2.20a). 1H NMR (300MHz, 
CDCl3) δ 7.54-7.46 (m, 3H), 7.43-7.38 (m, 2H), 7.31-7.19 (m, 5H), 6.8 (d, J = 18 Hz, 
1H), 6.71 (d, J = 15.9 Hz, 1H), 2.54 (s, 3H); 13C NMR (75MHz, CDCl3) δ 148.4, 145.7, 
136.3, 133.3, 129.8, 129.8, 129.2, 129.1, 127.2, 124.8, 121.3, 13.7.  HRMS (ESI, m/z): 





(E)-N-((E)-1-phenylpent-1-en-3-ylidene)aniline oxide (2.20b). Yield 22%; 3.3:1 E:Z. 
1H NMR (300MHz, CDCl3) δ 7.52-7.45 (m, 3H), 7.42-7.36 (m, 3H), 7.29-7.20 (m, 4H), 
6.80 (d, J = 15.9, Hz, 1H), 6.64 (d, J = 16.2 Hz, 1H), 3.03 (q, J = 7.5 Hz, 2H), 1.33 (t, J 
= 7.5); 13C NMR (75MHz, CDCl3) δ 152.6, 145.9, 138.0, 132.4, 129.7, 129.7, 129.1, 




(Z)-N-((E)-1-phenylhept-1-en-3-ylidene)aniline oxide (Z-2.20c). Yield 82% combined 
isomers; 1H NMR (300MHz, CDCl3) δ 7.92 (d, J = 16.8 Hz, 1H), 7.64-7.59 (m, 2H), 
7.52-7.44 (m, 3H), 7.42-7.32 (m, 3H), 7.19 (d, J = 68 Hz, 1H), 2.49-2.42 (m, 2H), 1.60-
1.45 (m, 2H), 1.30-1.17 (m, 2H), 0.79 (t, J = 7.2 Hz, 3H); 13C NMR (75MHz, CDCl3) δ 




(E)-N-((E)-1-phenylhept-1-en-3-ylidene)aniline oxide (E-2.20c). 1H NMR (300MHz, 
CDCl3) δ 7.48 (m, 3H), 7.39 (m, 2H), 7.25 (m, 5H), 6.79 (d, J = 15.9 Hz, 1H), 6.65 (d, J 
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= 15.9 Hz, 1H), 3.00 (m, 2H), 1.74 (m, 2H), 1.57 (m, 2H), 1.02 (t, J = 7.2 Hz, 3H); 13C 
NMR (75MHz, CDCl3) δ 151.7, 145.7, 136.3, 132.5, 129.6, 129.6, 129.0, 129.0, 127.1, 




(Z)-N-((E)-1,3-diphenylallylidene)aniline oxide (2.20d). Yield 52%; 1H NMR 
(300MHz, CDCl3) δ 8.18 (d, J = 16.5 Hz, 1H), 7.53 (m, 3H), 7.38-7.14 (m, 12H), 6.71 
(d, J = 16.2 Hz, 1H); 13C NMR (75MHz, CDCl3) δ 150.2, 147.4, 141.2, 136.6, 133.1, 
131.2, 129.7, 129.3, 129.1, 129.0, 128.9, 128.8, 128.0, 125.2, 122.3.  HRMS (ESI, m/z): 
[M]+ calc.: 300.1388; found: 300.1396. 
 
 
(E)-2-methyl-N-((E)-4-phenylbut-3-en-2-ylidene)aniline oxide (2.20e).  Yield 51%; 
2.7:1 E:Z. 1H  NMR (300MHz, CDCl3) δ 7.40-7.15 (m, 9H), 6.82 (d, J = 15.9 Hz, 1H), 
6.52 (d, J = 15.9 Hz, 1H), 2.54 (s, 3H), 2.25 (s, 3H); 13C NMR (75MHz, CDCl3) δ 148.3, 
144.6, 136.2, 133.4, 131.7, 129.6, 129.1, 129.1, 127.4, 127.2, 124.6, 120.6,17.0, 12.9. 




(E)-4-methyl-N-((E)-4-phenylbut-3-en-2-ylidene)aniline oxide (2.20f). Yield 67%; 
3.7:1 E:Z. 1H  NMR (300MHz, CDCl3) δ 7.40-7.20 (m, 9H), 6.84-6.70 (m, 2H), 2.51 (d, 
J = 2.1 Hz, 3H), 2.42 (d, J = 2.4 Hz, 3H); 13C NMR (75MHz, CDCl3) δ 147.9, 143.4, 
139.9, 136.4, 132.8, 130.2, 129.1, 129.0, 127.1, 124.5, 121.5.  HRMS (ESI, m/z): [M]+ 
calc.: 252.1388; found: 252.1382. 
  
 
(E)-4-chloro-N-((E)-4-phenylbut-3-en-2-ylidene)aniline oxide  (2.20g).  Yield  34%;  
2:1  E:Z.  1H  NMR (300MHz, CDCl3) δ 7.50-7.44 (m, 2H), 7.39-7.33 (m, 2H), 7.31-
7.23 (m, 4H), 6.84 (d, J =15.9 Hz, 1H), 6.69 (d, J = 15.9 Hz, 1H), 2.52 (s, 3H); 13C 
NMR (75MHz, CDCl3) δ 148.5, 144.2, 136.1, 135.6, 133.6, 130.0, 129.4, 129.2, 127.3, 





(Z)-N-((E)-4-(4-methoxyphenyl)but-3-en-2-ylidene)aniline oxide (Z-2.20h). Yield 
74% combined isomers; 1H NMR (300MHz, CDCl3) δ 7.93 (d, J = 16.5 Hz, 1H), 7.57 
(d, J = 8.7 Hz, 2H), 7.44 (m, 5H), 7.08 (d, J = 16.5 Hz, 1H), 6.91 (d, J = 8.7 Hz, 2H), 
3.84 (s, 3H), 2.11 (s, 3H); 13C NMR (75MHz, CDCl3) δ 161.0, 146.6, 145.2, 137.9, 
129.8, 129.5, 129.4, 129.3, 124.1, 118.6, 114.7, 55.7, 16.6.  HRMS (ESI, m/z): [M]+ 
calc.: 268.1338; found: 268.1332. 
 
 
(E)-N-((E)-4-(4-methoxyphenyl)but-3-en-2-ylidene)aniline oxide (E-2.20h). 1H NMR 
(300MHz, CDCl3) δ 7.45 (m, 5H), 7.17 (d, J = 8.7 Hz, 2H), 6.79 (m, 3H), 6.57 (d, J = 
15.9 Hz), 3.78 (s, 3H), 2.52 (s, 3H); 13C NMR (75MHz, CDCl3) δ 160.5, 148.4, 145.8, 
132.9, 129.7, 129.7, 129.1, 128.7, 124.8, 119.3, 114.6, 55.6, 13.6.  HRMS (ESI, m/z): 






(Z)-N-((E)-4-(4-methoxyphenyl)but-3-en-2-ylidene)-2-methylaniline oxide (Z-2.20i). 
Yield 49% combined isomers; 1H NMR (300MHz, CDCl3) δ 7.94 (d, J = 16.5 Hz, 1H), 
7.57 (m, 2H), 7.30 (m, 3H), 7.22 (m, 1H), 7.08 (d, J = 16.5 Hz, 1H), 6.91 (m, 2H), 3.84 
(s, 3H), 2.30 (s, 3H), 2.02 (s, 3H); 13C NMR (75MHz, CDCl3) δ 161.0, 145.6, 145.5, 
137.9, 131.8, 129.5, 129.3, 129.2, 127.5, 123.9, 118.1, 114.7, 55.7, 16.9, 15.7.  HRMS 
(ESI, m/z): [M]+ calc.: 282.1494; found: 282.1502. 
 
 
(E)-N-((E)-4-(4-methoxyphenyl)but-3-en-2-ylidene)-2-methylaniline oxide (E-2.20i). 
1H NMR (300MHz, CDCl3) δ 7.32 (m, 4H), 7.15 (m, 2H), 6.78 (m, 3H), 6.37 (d, J = 
14.7 Hz), 3.78 (s, 3H), 2.53 (s, 3H), 2.25 (s, 3H). 
 
 
(E)-N-((E)-pent-3-en-2-ylidene)aniline oxide (2.20j). Yield 70% estimated; 1H NMR 
(300MHz, CDCl3) δ 7.44 (m, 3H), 7.33 (m, 2H), 6.05 (m, 2H), 2.40 (s, 3H), 1.75 (d, J = 
5.4 Hz, 3H); 13C NMR (75MHz, CDCl3) δ 132.5, 129.8, 129.7, 129.5, 125.1, 124.6, 





(E)-3-methoxy-N-(4-methylpent-3-en-2-ylidene)aniline oxide  (2.20k).  Yield  70%  
estimated;  1H  NMR (300MHz, CDCl3) δ 7.28 (m, 1H), 6.91 (m, 3H), 5.66 (m, 1H), 
3.80 (s, 1H), 2.47 (s, 3H), 1.83 (d, J = 0.9 Hz, 3H), 1.70 (d, J = 1.2 Hz, 3H).  HRMS 
(ESI, m/z): [M]+ calc.: 206.1545; found: 206.1554. 
 
 
(E)-N-((E)-3-methylpent-3-en-2-ylidene)aniline oxide (2.20l). Yield: 20%. 1H NMR 
(300MHz, CDCl3) δ 7.32 (m, 6H), 2.38 (t, J = 1.2 Hz, 3H), 1.52 (s, 3H), 1.46 (d, J = 6.6 
Hz); 13C NMR (75MHz, CDCl3) δ 131.3, 129.7, 129.1, 129.0, 124.1, 123.6, 123.3.  
HRMS (ESI, m/z): [M]+ calc.: 190.1232; found: 190.1239. 
 
 
A.4 Experimental procedure for Chapter 3 section 2 
A.4.1 Experimental procedure for pyrroloindoline synthesis 
 The general procedure for indolenine synthesis found in section A.2.2 was 
adapted until the best results occurred.  A solution of the -unsaturated N-aryl 
ketonitrone (3 equiv.) and the activated alkyne 3.11 (0.2 M, 1 equiv.) in toluene was 
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stirred at 60 oC until TLC indicated the reaction was complete. The homogenous 
solution was concentrated in vacuo and the residue was purified by silica gel column 
chromatography, eluted with hexanes–ethyl acetate, to give the pyrroloindolines. 
 
A.4.2 Crystal and molecular structure determination of 3.9a 
X-ray Diffraction Laboratory 
Department of Chemistry 
Texas A&M University 
  TableA.6.  Crystal data and structure refinement for 3.9a. 
Empirical formula  C23 H32 N2 O4 
Formula weight  400.51 
Temperature  110(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
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Unit cell dimensions a = 6.2646(6) Å = 90°. 
 b = 18.5214(17) Å = 90°. 
 c = 18.8373(16) Å  = 90°. 
Volume 2185.7(3) Å3 
Z 4 
Density (calculated) 1.217 Mg/m3 
Absorption coefficient 0.668 mm-1 
F(000) 864 
Crystal size 0.12 x 0.02 x 0.02 mm3 
Theta range for data collection 4.78 to 60.00°. 
Index ranges -7<=h<=7, -20<=k<=20, -21<=l<=21 
Reflections collected 38180 
Independent reflections 3101 [R(int) = 0.1666] 
Completeness to theta = 60.00° 96.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9868 and 0.9241 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3101 / 0 / 272 
Goodness-of-fit on F2 1.010 
Final R indices [I>2sigma(I)] R1 = 0.0496, wR2 = 0.0532 
R indices (all data) R1 = 0.0856, wR2 = 0.0566 
Absolute structure parameter 0.01(19) 
Extinction coefficient 0.0218(5) 
Largest diff. peak and hole 0.157 and -0.167 e.Å-3 
 
 
Table A.7.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for 3.9a.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O(1) -5(4) 3061(1) -2016(1) 51(1) 
 110 
 
O(2) 3310(3) 2863(1) -2456(1) 49(1) 
O(3) 6641(3) 5037(1) -1236(1) 55(1) 
O(4) 1187(4) 6782(1) -212(1) 66(1) 
N(1) 2783(4) 3768(1) -1699(1) 45(1) 
N(2) 576(4) 3746(1) -628(1) 47(1) 
C(1) 1485(5) 4182(2) -1193(2) 47(1) 
C(2) 4878(5) 4088(2) -1876(2) 48(1) 
C(3) 5106(6) 4642(2) -1305(2) 47(1) 
C(4) 3162(5) 4667(2) -826(2) 48(1) 
C(5) 3610(6) 4243(2) -152(2) 50(1) 
C(6) 5197(6) 4334(2) 349(2) 53(1) 
C(7) 5180(6) 3889(2) 941(2) 58(1) 
C(8) 3556(6) 3377(2) 1023(2) 55(1) 
C(9) 1962(6) 3277(2) 534(2) 48(1) 
C(10) 2032(6) 3725(2) -67(2) 49(1) 
C(11) 1850(7) 3223(2) -2064(2) 49(1) 
C(12) 2675(6) 2410(2) -3064(2) 55(1) 
C(13) 4816(6) 2225(2) -3391(2) 69(1) 
C(14) 1357(5) 2864(2) -3558(2) 66(1) 
C(15) 1536(6) 1754(2) -2809(2) 72(1) 
C(16) 5006(6) 4408(2) -2621(2) 54(1) 
C(17) 3493(6) 5053(2) -2716(2) 64(1) 
C(18) 7283(5) 4628(2) -2808(2) 57(1) 
C(19) 2511(5) 5460(2) -683(2) 55(1) 
C(20) 626(5) 5525(2) -179(2) 49(1) 
C(21) -6(6) 6293(2) -52(2) 51(1) 
C(22) -2138(5) 6424(2) 286(2) 66(1) 
C(23) 279(5) 2722(2) 624(2) 59(1) 
________________________________________________________________________________  
 
Table A.8.   Bond lengths [Å] and angles [°] for 3.9a. 
_____________________________________________________  
O(1)-C(11)  1.204(4) 
 111 
 
O(2)-C(11)  1.351(4) 
O(2)-C(12)  1.475(3) 
O(3)-C(3)  1.215(3) 
O(4)-C(21)  1.212(3) 
N(1)-C(11)  1.354(4) 
N(1)-C(2)  1.478(4) 
N(1)-C(1)  1.469(3) 
N(2)-C(10)  1.397(4) 
N(2)-C(1)  1.452(3) 
N(2)-H(2N)  1.0926 
C(1)-C(4)  1.546(4) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.494(4) 
C(2)-C(16)  1.524(4) 
C(2)-H(2)  1.0000 
C(3)-C(4)  1.516(4) 
C(4)-C(5)  1.520(4) 
C(4)-C(19)  1.548(4) 
C(5)-C(6)  1.381(4) 
C(5)-C(10)  1.387(4) 
C(6)-C(7)  1.387(4) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.398(4) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.371(4) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.403(4) 
C(9)-C(23)  1.482(4) 
C(12)-C(15)  1.490(4) 
C(12)-C(14)  1.501(4) 
C(12)-C(13)  1.515(4) 
C(13)-H(13A)  0.9800 
C(13)-H(13B)  0.9800 
 112 
 
C(13)-H(13C)  0.9800 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
C(15)-H(15A)  0.9800 
C(15)-H(15B)  0.9800 
C(15)-H(15C)  0.9800 
C(16)-C(18)  1.525(4) 
C(16)-C(17)  1.535(4) 
C(16)-H(16)  1.0000 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
C(18)-H(18A)  0.9800 
C(18)-H(18B)  0.9800 
C(18)-H(18C)  0.9800 
C(19)-C(20)  1.521(4) 
C(19)-H(19A)  0.9900 
C(19)-H(19B)  0.9900 
C(20)-C(21)  1.496(4) 
C(20)-H(20A)  0.9900 
C(20)-H(20B)  0.9900 
C(21)-C(22)  1.500(4) 
C(22)-H(22A)  0.9800 
C(22)-H(22B)  0.9800 
C(22)-H(22C)  0.9800 
C(23)-H(23A)  0.9800 
C(23)-H(23B)  0.9800 
































































































































Symmetry transformations used to generate equivalent atoms:  
 
Table A.9.   Anisotropic displacement parameters  (Å2x 103) for 3.9a.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 41(2)  47(2) 66(2)  1(1) 1(1)  -6(1) 
O(2) 46(2)  35(1) 68(2)  -2(1) 0(1)  -1(1) 
O(3) 43(1)  43(1) 78(2)  -2(1) -5(1)  -6(1) 
O(4) 64(2)  46(2) 89(2)  -6(1) 1(2)  -6(2) 
N(1) 41(2)  33(2) 60(2)  -4(2) 0(2)  -3(2) 
N(2) 40(2)  40(2) 60(2)  1(2) 0(2)  -8(2) 
C(1) 43(2)  35(2) 64(2)  -2(2) -12(2)  3(2) 
C(2) 43(2)  30(2) 72(2)  9(2) -3(2)  -3(2) 
C(3) 43(2)  30(2) 69(3)  6(2) -11(2)  10(2) 
C(4) 43(2)  33(2) 70(3)  -1(2) -2(2)  -2(2) 
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C(5) 43(2)  38(2) 67(3)  6(2) 2(2)  -7(2) 
C(6) 48(2)  42(2) 70(3)  -8(2) -4(2)  -13(2) 
C(7) 54(2)  49(2) 70(3)  9(2) -12(2)  3(2) 
C(8) 57(2)  47(2) 60(3)  4(2) -1(2)  -2(2) 
C(9) 41(2)  37(2) 67(3)  3(2) 9(2)  4(2) 
C(10) 34(2)  46(2) 69(3)  0(2) 4(2)  -3(2) 
C(11) 45(2)  40(2) 62(3)  8(2) -1(2)  -2(2) 
C(12) 54(3)  39(2) 72(3)  -8(2) 3(2)  -3(2) 
C(13) 61(3)  69(3) 77(3)  -14(2) 9(2)  9(3) 
C(14) 69(3)  60(2) 69(3)  -1(2) -9(2)  8(2) 
C(15) 87(3)  50(2) 78(3)  -5(2) 12(2)  -17(3) 
C(16) 56(2)  37(2) 70(3)  6(2) -1(2)  -7(2) 
C(17) 61(2)  57(2) 75(3)  16(2) -7(2)  3(2) 
C(18) 48(2)  50(2) 74(3)  9(2) 5(2)  -1(2) 
C(19) 51(2)  44(2) 70(3)  -7(2) 2(2)  -3(2) 
C(20) 44(2)  43(2) 61(2)  0(2) -1(2)  4(2) 
C(21) 50(2)  47(2) 56(2)  -7(2) -3(2)  0(2) 
C(22) 59(3)  57(3) 81(3)  -18(2) 1(2)  7(2) 
C(23) 63(2)  44(2) 70(2)  9(2) 2(2)  -2(2) 
______________________________________________________________________________  
 
Table A.10.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for 3.9a. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(2N) -84 3227 -795 70(10) 
H(1) 368 4475 -1440 57 
H(2) 6015 3714 -1820 58 
H(6) 6270 4692 290 64 
H(7) 6268 3930 1290 69 
H(8) 3557 3085 1437 66 
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H(13A) 4594 1927 -3815 104 
H(13B) 5679 1957 -3046 104 
H(13C) 5559 2671 -3524 104 
H(14A) 2173 3293 -3697 99 
H(14B) 43 3014 -3317 99 
H(14C) 994 2583 -3981 99 
H(15A) 1553 1384 -3181 108 
H(15B) 56 1878 -2693 108 
H(15C) 2250 1567 -2384 108 
H(16) 4557 4025 -2964 65 
H(17A) 3519 5211 -3213 97 
H(17B) 3956 5451 -2409 97 
H(17C) 2039 4909 -2587 97 
H(18A) 8241 4216 -2737 86 
H(18B) 7730 5028 -2503 86 
H(18C) 7341 4780 -3306 86 
H(19A) 3746 5722 -480 66 
H(19B) 2140 5694 -1140 66 
H(20A) -605 5259 -379 59 
H(20B) 1003 5298 280 59 
H(22A) -2392 6945 322 98 
H(22B) -2158 6210 762 98 
H(22C) -3259 6204 -4 98 
H(23A) -1127 2944 558 88 
H(23B) 371 2517 1103 88 









A.5 Experimental procedure for Chapter 3 section 3 
A.5.1 Product distribution determination 
A.5.1.1 Spectra data for compounds 
 
 
methyl 8-methyl-2-oxo-2,3,4,4a,9,9a-hexahydro-1H-carbazole-4a-carboxylate (3.13)  
1H NMR (300 MHz, CDCl3) δ 7.18 (d, J = 7.1 Hz, 1H), 6.95 (d, J = 7.4 Hz, 1H), 6.72 (t, 
J = 7.5 Hz, 1H), 4.89 (t, J = 3.5 Hz, 1H), 3.81 (s, 3H), 2.78 (dd, J = 16.5, 3.6 Hz, 1H), 
2.65 (dd, J = 16.5, 3.5 Hz, 1H), 2.48 – 2.34 (m, 1H), 2.34 – 2.19 (m, 2H), 2.08 (s, 3H), 
2.15 – 1.99 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 210.7, 174.4, 148.9, 130.3, 128.3, 122.3, 119.6, 




(E)-N-((E)-3-methylpent-3-en-2-ylidene)aniline oxide (3.14). Yield: 20%. 1H NMR 
(300 MHz, CDCl3) δ 8.74 (bs, 1H), 8.04 (d, J = 8.0 Hz, 1H), 7.92 (d, J = 3.0 Hz, 1H), 
7.20 (t, J = 7.6 Hz, 1H), 7.08 (d, J = 7.2 Hz, 1H), 3.93 (s, 3H), 2.51 (s, 3H); 13C NMR 
(75 MHz, CDCl3) δ 166.0, 135.8, 130.9, 125.5, 123.9, 122.4, 120.8, 119.3, 109.3, 51.3, 
16.7.  HRMS (ESI, m/z): [M]- calc.: 188.0712; found: 188.0702. 
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A.5.1.2 Ratio determination 
 Indolenine was taken up in solvent and temperature adjusted.  Acid was added 
followed by dropwise addition of the base.  The reaction was then followed by TLC for 
disappearance of starting material.  If toluene was solvent, the reaction was loaded onto 
a column and eluted.  Otherwise, the solvent was removed under vacuum and then 
loaded onto column.  A quick column separated 3.15 (more polar) from 3.13 and 3.14.  
 1H NMR was then used to determine the ratio and yield of each compound by 
utilizing the integration of the methyl ester.  The peak for 3.13 appeared at 3.83 ppm and 
for 3.14 at 3.92 ppm (FigureA.1).  By setting the peak at 3.8 ppm to 1 and plugging the 
integration of the peak at 3.9 into Scheme A.1, the mass of 3.13 and 3.14 could be 
determined and yields calculated.  This was need to calculate the true ratio while 3.15 
was being formed.  Once 3.15 was eliminated, the ratio was simply read from the 
spectra. 
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Figure A.1 Example spectrum in ratio determination 
 
A.5.2 Crystal and molecular structure determination of 3.15 
X-ray Diffraction Laboratory 
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Table A.11.  Crystal data and structure refinement for 3.15. 
Empirical formula  C36 H42 N2 O8 
Formula weight  630.72 
Temperature  110(2) K 
Wavelength  1.54178 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.5078(7) Å = 90.062(6)°. 
 b = 9.5433(7) Å = 98.589(6)°. 
 c = 20.0777(15) Å  = 90.427(6)°. 
Volume 1611.8(2) Å3 
Z 2 
Density (calculated) 1.300 Mg/m3 




Crystal size 0.10 x 0.05 x 0.01 mm3 
Theta range for data collection 4.45 to 59.99°. 
Index ranges -9<=h<=8, -10<=k<=10, -22<=l<=22 
Reflections collected 28556 
Independent reflections 4259 [R(int) = 0.1315] 
Completeness to theta = 59.99° 88.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9925 and 0.9288 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4259 / 0 / 426 
Goodness-of-fit on F2 1.008 
Final R indices [I>2sigma(I)] R1 = 0.0643, wR2 = 0.0923 
R indices (all data) R1 = 0.1113, wR2 = 0.0973 
Extinction coefficient 0.0041(2) 
Largest diff. peak and hole 0.300 and -0.291 e.Å-3 
 
Table A.12.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for 3.15.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O(1A) 3709(4) 3550(3) 3949(1) 43(1) 
N(1A) 1800(4) 6405(3) 2809(1) 21(1) 
C(1A) 544(5) 5512(4) 3027(2) 19(1) 
O(2A) 2413(4) 5555(3) 794(1) 35(1) 
C(2A) 1248(5) 4099(4) 3275(2) 25(1) 
O(3A) -2744(3) 5631(3) 3078(1) 34(1) 
C(3A) 2532(5) 4255(4) 3869(2) 26(1) 
O(4A) -2480(3) 7110(3) 3943(1) 41(1) 
C(4A) 2257(5) 5397(4) 4370(2) 30(1) 
C(5A) 502(5) 5785(4) 4302(2) 25(1) 
C(6A) -98(5) 6383(4) 3584(2) 21(1) 
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C(7A) 591(5) 7840(4) 3506(2) 21(1) 
C(8A) 371(5) 9067(4) 3836(2) 22(1) 
C(9A) 1167(5) 10262(4) 3680(2) 28(1) 
C(10A) 2164(5) 10201(4) 3189(2) 29(1) 
C(11A) 2405(5) 8977(4) 2870(2) 26(1) 
C(12A) 1615(5) 7788(4) 3033(2) 19(1) 
C(13A) 2238(5) 6151(4) 2141(2) 22(1) 
C(14A) 991(5) 6652(4) 1575(2) 28(1) 
C(15A) 1297(5) 6279(4) 880(2) 25(1) 
C(16A) 107(5) 6800(4) 304(2) 35(1) 
C(17A) -1897(5) 6307(4) 3486(2) 25(1) 
C(18A) -4193(5) 7034(5) 3919(2) 59(2) 
C(1B) 5093(5) 2577(4) 1895(2) 21(1) 
N(1B) 6527(4) 1724(3) 2141(1) 21(1) 
O(1B) 7843(4) 4521(3) 1107(1) 40(1) 
C(2B) 5634(5) 4020(4) 1672(2) 26(1) 
O(2B) 8458(4) 2496(3) 4184(1) 37(1) 
C(3B) 6630(5) 3846(4) 1127(2) 25(1) 
O(3B) 1836(4) 2326(3) 1804(2) 44(1) 
C(4B) 6028(5) 2770(4) 587(2) 27(1) 
O(4B) 1561(4) 805(3) 954(1) 45(1) 
C(5B) 4332(5) 2327(4) 614(2) 27(1) 
C(6B) 4156(5) 1705(4) 1316(2) 22(1) 
C(7B) 4940(5) 266(4) 1409(2) 20(1) 
C(8B) 4558(5) -986(4) 1082(2) 28(1) 
C(9B) 5472(5) -2147(4) 1259(2) 31(1) 
C(10B) 6751(5) -2068(4) 1773(2) 30(1) 
C(11B) 7164(5) -810(4) 2103(2) 26(1) 
C(12B) 6273(5) 344(4) 1914(2) 20(1) 
C(13B) 7387(5) 2001(4) 2818(2) 23(1) 
C(14B) 6465(5) 1448(4) 3374(2) 29(1) 
C(15B) 7278(5) 1773(4) 4070(2) 26(1) 
C(16B) 6513(5) 1148(4) 4632(2) 33(1) 
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C(17B) 2391(6) 1635(5) 1391(2) 39(1) 
C(18B) -132(7) 797(7) 1071(3) 41(2) 
C(1B') 136(18) 1953(16) 1664(7) 33(5) 
________________________________________________________________________________ 
 
Table A.13.   Bond lengths [Å] and angles [°] for  3.15. 
_____________________________________________________  
O(1A)-C(3A)  1.202(5) 
N(1A)-C(12A)  1.412(4) 
N(1A)-C(13A)  1.465(4) 
N(1A)-C(1A)  1.478(4) 
C(1A)-C(2A)  1.533(5) 
C(1A)-C(6A)  1.559(5) 
C(1A)-H(1A)  1.0000 
O(2A)-C(15A)  1.212(5) 
C(2A)-C(3A)  1.499(5) 
C(2A)-H(2AA)  0.9900 
C(2A)-H(2AB)  0.9900 
O(3A)-C(17A)  1.192(4) 
C(3A)-C(4A)  1.525(5) 
O(4A)-C(17A)  1.347(4) 
O(4A)-C(18A)  1.453(5) 
C(4A)-C(5A)  1.528(5) 
C(4A)-H(4AA)  0.9900 
C(4A)-H(4AB)  0.9900 
C(5A)-C(6A)  1.565(5) 
C(5A)-H(5AA)  0.9900 
C(5A)-H(5AB)  0.9900 
C(6A)-C(17A)  1.514(5) 
C(6A)-C(7A)  1.522(5) 
C(7A)-C(8A)  1.373(5) 
C(7A)-C(12A)  1.382(5) 
C(8A)-C(9A)  1.383(5) 
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C(8A)-H(8A)  0.9500 
C(9A)-C(10A)  1.395(5) 
C(9A)-H(9A)  0.9500 
C(10A)-C(11A)  1.362(5) 
C(10A)-H(10A)  0.9500 
C(11A)-C(12A)  1.379(5) 
C(11A)-H(11A)  0.9500 
C(13A)-C(14A)  1.514(5) 
C(13A)-H(13A)  0.9900 
C(13A)-H(13B)  0.9900 
C(14A)-C(15A)  1.500(5) 
C(14A)-H(14A)  0.9900 
C(14A)-H(14B)  0.9900 
C(15A)-C(16A)  1.507(5) 
C(16A)-H(16A)  0.9800 
C(16A)-H(16B)  0.9800 
C(16A)-H(16C)  0.9800 
C(18A)-H(18A)  0.9800 
C(18A)-H(18B)  0.9800 
C(18A)-H(18C)  0.9800 
C(1B)-N(1B)  1.494(5) 
C(1B)-C(2B)  1.537(5) 
C(1B)-C(6B)  1.545(5) 
C(1B)-H(1B)  1.0000 
N(1B)-C(12B)  1.398(5) 
N(1B)-C(13B)  1.467(4) 
O(1B)-C(3B)  1.219(5) 
C(2B)-C(3B)  1.492(5) 
C(2B)-H(2BA)  0.9900 
C(2B)-H(2BB)  0.9900 
O(2B)-C(15B)  1.207(5) 
C(3B)-C(4B)  1.521(5) 
O(3B)-C(17B)  1.210(5) 
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O(3B)-C(1B')  1.473(15) 
C(4B)-C(5B)  1.509(5) 
C(4B)-H(4BA)  0.9900 
C(4B)-H(4BB)  0.9900 
O(4B)-C(17B)  1.303(5) 
O(4B)-C(18B)  1.493(6) 
C(5B)-C(6B)  1.558(5) 
C(5B)-H(5BA)  0.9900 
C(5B)-H(5BB)  0.9900 
C(6B)-C(7B)  1.531(5) 
C(6B)-C(17B)  1.533(6) 
C(7B)-C(8B)  1.376(5) 
C(7B)-C(12B)  1.405(5) 
C(8B)-C(9B)  1.375(5) 
C(8B)-H(8B)  0.9500 
C(9B)-C(10B)  1.384(5) 
C(9B)-H(9B)  0.9500 
C(10B)-C(11B)  1.388(5) 
C(10B)-H(10B)  0.9500 
C(11B)-C(12B)  1.363(5) 
C(11B)-H(11B)  0.9500 
C(13B)-C(14B)  1.547(5) 
C(13B)-H(13C)  0.9900 
C(13B)-H(13D)  0.9900 
C(14B)-C(15B)  1.495(5) 
C(14B)-H(14C)  0.9900 
C(14B)-H(14D)  0.9900 
C(15B)-C(16B)  1.506(5) 
C(16B)-H(16D)  0.9800 
C(16B)-H(16E)  0.9800 
C(16B)-H(16F)  0.9800 
C(18B)-H(18D)  0.9800 
C(18B)-H(18E)  0.9800 
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C(18B)-H(18F)  0.9800 
C(1B')-H(1BA)  0.9800 
C(1B')-H(1BB)  0.9800 



























































































































































































Symmetry transformations used to generate equivalent atoms:  
  
 
Table A.14.   Anisotropic displacement parameters  (Å2x 103) for 3.15.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1A) 39(2)  35(2) 55(2)  3(2) 4(2)  9(2) 
N(1A) 22(2)  27(2) 16(2)  -2(2) 6(2)  -2(2) 
C(1A) 22(3)  14(2) 21(2)  -2(2) 4(2)  -5(2) 
O(2A) 37(2)  44(2) 26(2)  1(2) 8(1)  7(2) 
C(2A) 32(3)  24(3) 19(2)  0(2) 4(2)  -4(2) 
O(3A) 29(2)  41(2) 28(2)  -11(2) -4(1)  -10(2) 
C(3A) 29(3)  23(3) 30(3)  8(2) 12(2)  -5(2) 
O(4A) 25(2)  47(2) 52(2)  -26(2) 13(2)  -12(2) 
C(4A) 33(3)  35(3) 23(2)  3(2) 4(2)  -8(2) 
C(5A) 30(3)  23(3) 20(2)  7(2) 2(2)  -4(2) 
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C(6A) 20(3)  29(3) 15(2)  -5(2) 4(2)  -6(2) 
C(7A) 20(3)  23(3) 20(2)  6(2) 2(2)  -4(2) 
C(8A) 27(3)  16(3) 23(2)  -6(2) 3(2)  -3(2) 
C(9A) 38(3)  17(3) 29(3)  0(2) 3(2)  -7(2) 
C(10A) 29(3)  22(3) 34(3)  9(2) 0(2)  -9(2) 
C(11A) 23(3)  26(3) 28(3)  2(2) 3(2)  -2(2) 
C(12A) 22(3)  21(3) 14(2)  -2(2) -2(2)  -2(2) 
C(13A) 29(3)  21(3) 17(2)  -2(2) 6(2)  -6(2) 
C(14A) 31(3)  32(3) 21(2)  2(2) 6(2)  -1(2) 
C(15A) 29(3)  27(3) 22(2)  3(2) 9(2)  -2(2) 
C(16A) 31(3)  48(3) 25(3)  11(2) -1(2)  0(2) 
C(17A) 32(3)  21(3) 24(3)  3(2) 11(2)  1(2) 
C(18A) 21(4)  67(4) 93(4)  -40(3) 21(3)  -12(3) 
C(1B) 23(3)  18(3) 22(2)  -2(2) 3(2)  -1(2) 
N(1B) 22(2)  23(2) 15(2)  1(2) -5(1)  -3(2) 
O(1B) 35(2)  44(2) 40(2)  -2(2) 6(2)  -20(2) 
C(2B) 31(3)  21(3) 25(2)  0(2) 1(2)  -2(2) 
O(2B) 41(2)  43(2) 25(2)  -1(2) 1(2)  -12(2) 
C(3B) 27(3)  26(3) 20(2)  6(2) -2(2)  -1(2) 
O(3B) 23(2)  58(2) 55(2)  5(2) 15(2)  -2(2) 
C(4B) 29(3)  35(3) 15(2)  1(2) 3(2)  0(2) 
O(4B) 21(2)  53(2) 58(2)  -4(2) -4(2)  -9(2) 
C(5B) 34(3)  28(3) 18(2)  2(2) 2(2)  -7(2) 
C(6B) 18(3)  27(3) 24(2)  4(2) 6(2)  -4(2) 
C(7B) 24(3)  20(3) 17(2)  1(2) 4(2)  -7(2) 
C(8B) 29(3)  30(3) 22(2)  1(2) -4(2)  -4(2) 
C(9B) 49(4)  20(3) 22(2)  -1(2) 4(2)  -7(2) 
C(10B) 42(3)  24(3) 23(3)  4(2) 7(2)  -5(2) 
C(11B) 28(3)  27(3) 23(2)  3(2) 4(2)  -2(2) 
C(12B) 26(3)  20(3) 15(2)  -1(2) 2(2)  -5(2) 
C(13B) 27(3)  25(3) 16(2)  2(2) -1(2)  -6(2) 
C(14B) 38(3)  31(3) 14(2)  4(2) -4(2)  -12(2) 
C(15B) 24(3)  25(3) 28(3)  1(2) -2(2)  -2(2) 
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C(16B) 35(3)  40(3) 24(3)  5(2) 5(2)  2(2) 
C(17B) 24(3)  45(4) 44(3)  28(3) -6(3)  -4(3) 
C(18B) 24(5)  45(5) 53(5)  -8(4) 2(3)  -11(3) 
______________________________________________________________________________ 
 
Table A.15.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for 3.15. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1A) -326 5357 2640 23 
H(2AA) 391 3492 3400 30 
H(2AB) 1690 3633 2904 30 
H(4AA) 2890 6239 4291 36 
H(4AB) 2625 5066 4834 36 
H(5AA) 353 6495 4647 30 
H(5AB) -133 4945 4381 30 
H(8A) -318 9094 4167 27 
H(9A) 1036 11120 3905 34 
H(10A) 2687 11030 3074 35 
H(11A) 3102 8944 2542 31 
H(13A) 2403 5134 2085 26 
H(13B) 3257 6637 2110 26 
H(14A) -51 6250 1642 34 
H(14B) 914 7684 1607 34 
H(16A) 458 6551 -124 52 
H(16B) 21 7821 334 52 
H(16C) -932 6367 325 52 
H(18A) -4715 7375 3482 89 
H(18B) -4506 7616 4279 89 
H(18C) -4515 6060 3980 89 
H(1B) 4437 2694 2265 26 
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H(2BA) 4693 4595 1506 31 
H(2BB) 6255 4511 2061 31 
H(4BA) 6100 3171 138 32 
H(4BB) 6718 1935 647 32 
H(5BA) 4001 1615 260 32 
H(5BB) 3626 3146 522 32 
H(8B) 3668 -1048 735 33 
H(9B) 5226 -3008 1028 37 
H(10B) 7352 -2885 1901 35 
H(11B) 8048 -754 2452 31 
H(13C) 7563 3023 2877 28 
H(13D) 8440 1546 2865 28 
H(14C) 5393 1868 3310 35 
H(14D) 6331 420 3324 35 
H(16D) 5412 1468 4595 50 
H(16E) 7104 1446 5066 50 
H(16F) 6527 124 4600 50 
H(18D) -553 1750 1023 61 
H(18E) -195 452 1526 61 
H(18F) -759 182 739 61 
H(1BA) -393 2551 1303 49 
H(1BB) -350 2090 2072 49 











A.6 Experimental procedure for Chapter 4 
A.6.1 General experimental procedure 
 
 
A.6.1.1 Using Et3B 
 BOX ligand (0.12 mmol) and Cu(OTf)2 (0.10 mmol) were stirred in dioxane (2 
mL) for 1 hour.  The Michael acceptor (0.75 mmol) was added and stirred for 10 min 
prior to the dropwise addition of the activated tryptamine derivative.  The flask was 
rinsed with 1mL of dioxane and also added.  The tryptamine derivative (0.50 mmol) was 
activated by stirring in dioxane (2 mL) with KOt-Bu (0.55 mmol) for 30 min prior to 
addition of Et3B (0.55 mmol) and subsequent stirring for 1 hour.  The reaction was 
diluted with EtOAc and quenched with H2O.  The aqueous layer was extracted with 
EtOAc (3x).  The combined organic layers were dried, filtered, and concentrated prior to 
column chromatography. 
 
A.6.1.2 Using SnCl4 
 Tryptamine derivative (0.20 mmol), Michael acceptor (0.20 mmol), and (S)-
BINOL (0.04 mmol) were added to a flask.  CH2Cl2 (1.5 mL) was added followed by a 1 
M solution of SnCl4 (0.24 mmol) in CH2Cl2 and stirred for 1 hour.  The reaction was 
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quenched by diluting with 1 mL of MeCN and 1 mL of 1 M HCl followed by 5 mL H2O.  
The aqueous layer was then extracted with EtOAc (3x) and then the combined organic 
layers was washed with saturated aqueous NaHCO3.  The organic layer was dried, 
filtered, and concentrated prior to column chromatography. 
 
A.6.2 Spectra data for compounds 
 
 
tert-butyl (2-(1-(2-nitro-1-phenylethyl)-1H-indol-3-yl)ethyl)carbamate (A.1).  1H 
NMR (300 MHz, CDCl3) δ 7.65 – 7.54 (m, 1H), 7.43 – 7.06 (m, 9H), 7.03 (s, 1H), 6.37 
(dt, J = 18.9, 9.4 Hz, 1H), 5.17 (qd, J = 13.3, 7.6 Hz, 2H), 3.43 (dd, J = 13.0, 6.6 Hz, 
2H), 2.93 (t, J = 7.0 Hz, 2H), 1.45 (s, 9H). 
 
 
4a-(2-nitro-1-phenylethyl)-2,3,4,4a-tetrahydro-1H-carbazole (4.3). Two 
diastereomers.  1H NMR (300 MHz, CDCl3) δ 8.02 (d, J = 13.7 Hz, 1H), 7.65 – 6.96 (m, 
17H), 5.06 (ddd, J = 10.1, 6.5, 3.4 Hz, 1H), 4.67 – 4.47 (m, 4H), 4.38 (ddd, J = 12.7, 3.4, 
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1.3 Hz, 1H), 3.53 – 3.25 (m, 4H), 1.82 – 1.60 (m, 3H), 1.56 – 1.43 (m, 1H), 1.39 – 1.21 
(m, 2H), 1.16 (t, J = 7.0 Hz, 1H), 0.92 – 0.79 (m, 5H). 
 
3-(3-(1-tosyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-3a-
yl)propanoyl)oxazolidin-2-one (A.2).  1H NMR (300 MHz, CDCl3) δ 7.73 (d, J = 8.3 
Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 7.07 (td, J = 7.7, 1.2 Hz, 1H), 6.99 (d, J = 6.8 Hz, 1H), 
6.73 (td, J = 7.4, 0.9 Hz, 1H), 6.60 (d, J = 7.8 Hz, 1H), 5.14 (s, 1H), 4.86 (s, 1H), 4.37 – 
4.28 (m, 2H), 4.03 – 3.94 (m, 1H), 3.92 – 3.83 (m, 1H), 3.46 – 3.37 (m, 1H), 3.09 (td, J 
= 10.7, 5.9 Hz, 1H), 2.93 – 2.80 (m, 1H), 2.78 – 2.65 (m, 1H), 2.42 (s, 3H), 2.19 – 2.09 
(m, 1H), 2.07 – 1.99 (m, 1H), 1.95 – 1.85 (m, 1H), 1.81 – 1.69 (m, 1H).  Chiral HPLC 
(Chiralpak IC, 50:50 hexane:iPrOH, 0.5 mL/min) 




Peak Table Detector A Ch1 210nm 
Peak# Ret. Time Area Height Area % Height % 
1 60.597 31993540 199331 50.096 54.686 
2 74.190 31871387 165170 49.904 45.314 
Total  63864927 364501 100.000 100.000 
 
Peak Table Detector A Ch2 254nm 
Peak# Ret. Time Area Height Area % Height % 
1 60.585 7064223 45646 50.848 55.091 
2 74.149 6828508 37209 49.152 44.909 
Total  13892731 82855 100.000 100.000 
 
4,4-dimethyl-3-(3-(1-tosyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-3a-
yl)propanoyl)oxazolidin-2-one (A.3).  Spectra contains 1:1 product to starting 
tryptamine derivative.  Chiral HPLC (Chiralpak IC, 50:50 hexane:iPrOH, 1.0 mL/min) 




Peak Table Detector A Ch1 210nm 
Peak# Ret. Time Area Height Area % Height % 
1 26.515 8837756 146871 49.956 56.101 
2 33.378 8853428 114924 50.044 43.899 
Total  17691183 261795 100.000 100.000 
 
Peak Table Detector A Ch2 254nm 
Peak# Ret. Time Area Height Area % Height % 
1 26.521 1992809 33361 50.063 56.164 
2 33.377 1987777 26039 49.937 43.836 




b]indol-3a-yl)butanoate (A.4). Two conformers.  1H NMR (300 MHz, CDCl3) δ 7.81 – 
7.63 (m, 2H), 7.31 (d, J = 8.0 Hz, 2H), 7.16 – 6.95 (m, 2H), 6.79 – 6.69 (m, 1H), 6.63 
(dd, J = 10.9, 7.8 Hz, 1H), 5.53 (s, 0.7H), 5.28 (s, 0.3H), 4.93 (s, 0.3H), 4.89 (s, 0.7H), 
4.32 (t, J = 8.2 Hz, 2H), 4.02 – 3.93 (m, 2H), 3.92 – 3.78 (m, 2H), 3.48 – 3.00 (m, 4H), 
2.81 (dd, J = 18.3, 3.1 Hz, 1H), 2.42 (s, 0.3H), 2.42 (s, 0.7H), 2.21 – 2.09 (m, 1H), 1.98 
– 1.89 (m, 1H), 1.19 (t, J = 7.1 Hz, 0.3H), 1.12 (t, J = 7.1 Hz, 0.7H).  The dr for the 
BOX ligand was determined to be 2.4:1 and the dr for (R)-BINOL was calculated to be 
1.9:1 with the greater isomer having 76% ee by chiral HPLC (Chiralpak IC, 50:50 
hexane:iPrOH, 0.75 mL/min) 
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Chiral Chromatogram for A.4 from BOX ligand 
 
 
Peak Table Detector A Ch1 210nm 
Peak# Ret. Time Area Height Area % Height % 
1 34.065 4930038 45632 36.637 49.267 
2 50.086 1996126 14554 14.834 15.713 
3 55.696 1998018 12273 14.848 13.251 
4 77.702 4532330 20162 33.681 21.768 
Total  13456512 92621 100.000 100.000 
 
Peak Table Detector A Ch2 254nm 
Peak# Ret. Time Area Height Area % Height % 
1 34.087 1117025 10557 37.428 50.428 
2 50.033 450421 3212 15.092 15.342 
3 55.792 417976 2620 14.005 12.514 
4 77.727 999026 4547 33.474 21.717 
Total  2984449 20935 100.000 100.000 





Peak Table Detector A Ch1 210nm 
Peak# Ret. Time Area Height Area % Height % 
1 35.032 13809116 110355 36.906 39.772 
2 38.479 13559417 106829 36.239 38.501 
3 49.854 4549530 30285 12.159 10.915 
4 55.810 3633192 21080 9.710 7.597 
5 77.588 1865822 8922 4.987 3.215 
Total  37417078 277471 100.000 100.000 
 
Peak Table Detector A Ch2 254nm 
Peak# Ret. Time Area Height Area % Height % 
1 35.016 1911042 14865 33.821 36.527 
2 38.469 1649519 13165 29.193 32.349 
3 49.860 910659 6296 16.117 15.470 
4 55.656 731799 4319 12.951 10.612 
5 77.573 447417 2052 7.918 5.041 






A.7 Experimental procedure for Chapter 5 
A.7.1 General experimental procedure 
 Styrene derivative (1.4 mmol) was added to a solution of iron (II) chloride (9.3 
mg, 0.07 mmol) in THF (3 mL) at room temperature.  Cyclopentylmagnesium bromide 
(1.4 mL, 2M in Et2O, 2.8 mmol) was added dropwise and the reaction stirred for 2 
hours.  The reaction was cooled to 0 oC and a solution of hydroxylamine (0.7 mmol) in 
THF (1 mL) was added over 1 hour.  After 30 min, the reaction was quenched with sat. 
aq. NaHCO3 and Et2O was added.  The aqueous layer was extracted with Et2O (3x).  The 
combined organic layer was then extracted with 1M HCl (3x).  NaOH pellets were 
added until the solution was strongly basic.  The aqueous layer was then extracted with 
Et2O (3x), dried, and concentrated in vacuo to give the product as a clear to yellow oil 
that was pure by 1H NMR. 
 
A.7.2 Spectra data for compounds 
 
 
1-(1-phenylethyl)piperidine (5.3a).  Prepared according to the general procedure in 71% 
yield as light yellow oil. Spectral data for this compound were consistent with those 





1-(1-phenylethyl)pyrrolidine (5.3b).  Prepared according to the general procedure in 
70% yield as light yellow oil. Spectral data for this compound were consistent with those 
found in the literature.60 
 
 
1-(1-phenylethyl)azepane (5.3c).  Prepared according to the general procedure in 61% 
yield as light yellow oil. Spectral data for this compound were consistent with those 
found in the literature.60 
 
 
4-(1-phenylethyl)morpholine  (5.3d).  Prepared according to the general procedure in 
52% yield as light yellow oil. Spectral data for this compound were consistent with those 
found in the literature.60 
 
 
N,N-diethyl-1-phenylethanamine (5.3e).  Prepared according to the general procedure 
in 80% yield as light yellow oil. Spectral data for this compound were consistent with 




1-(1-(m-tolyl)ethyl)piperidine (5.3g). Prepared according to the general procedure in 
66% yield as light yellow oil.  1H NMR (300 MHz, CDCl3) δ 7.20 (t, J = 7.3 Hz, 1H), 
7.16 – 7.00 (m, 3H), 3.34 (q, J = 6.8 Hz, 1H), 2.48 – 2.25 (m, 4H), 2.35 (s, 3H), 1.62 – 
1.50 (m, 4H), 1.45 – 1.31 (m, 2H), 1.36 (d, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δ 144.0, 137.7, 128.6, 128.0, 127.6, 125.0, 65.5, 51.8, 26.4, 24.7, 21.6, 19.7. HRMS 
(ESI, m/z): [M]+ calc.: 204.1752; found: 204.1753.  
 
 
1-(1-(p-tolyl)ethyl)piperidine (5.3h). Prepared according to the general procedure in 
62% yield as light yellow oil.  1H NMR (300 MHz, CDCl3) δ 7.21 – 7.15 (m, 2H), 7.15 
– 7.09 (m, 2H), 3.38 (q, J = 6.8 Hz, 1H), 2.47 – 2.26 (m, 4H), 2.33 (s, 3H), 1.61 – 1.50 
(m, 4H), 1.43 – 1.32 (m, 2H), 1.36 (d, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
140.7, 136.4, 128.8, 127.9, 65.0, 51.6, 26.4, 24.7, 21.2, 19.6. HRMS (ESI, m/z): [M]+ 
calc.: 204.1752; found: 204.1750. 
 
 
1-(1-(o-tolyl)ethyl)piperidine (5.3i). Prepared according to the general procedure in 
49% yield as light yellow oil.  1H NMR (300 MHz, CDCl3) δ 7.45 (d, J = 7.4 Hz, 1H), 
7.23 – 7.09 (m, 3H), 3.56 (q, J = 6.6 Hz, 1H), 2.55 – 2.41 (m, 2H), 2.37 (s, 3H), 2.39 – 
2.28 (m, 2H), 1.59 – 1.49 (m, 4H), 1.48 – 1.36 (m, 2H), 1.29 (d, J = 6.7 Hz, 3H); 13C 
NMR (75 MHz, CDCl3) δ 143.7, 136.0, 130.4, 126.8, 126.2, 125.9, 60.9, 51.8, 26.5, 





1-(1-(4-methoxyphenyl)ethyl)piperidine (5.3j). Prepared according to the general 
procedure in 55% yield as light yellow oil.  1H NMR (300 MHz, CDCl3) δ 7.25 – 7.18 
(m, 1H), 6.92 – 6.86 (m, 2H), 6.80 – 6.74 (m, 1H), 3.80 (s, 3H), 3.36 (q, J = 6.8 Hz, 1H), 
2.46 – 2.29 (m, 4H), 1.62 – 1.48 (m, 4H), 1.44 – 1.36 (m, 2H), 1.36 (d, J = 6.8 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δ 159.5, 145.9, 129.0, 120.2, 113.5, 111.9, 65.3, 55.2, 51.6, 
26.4, 24.7, 19.6. HRMS (ESI, m/z): [M]+ calc.: 220.1701; found: 220.1692.  
 
 
1-(1-(3-methoxyphenyl)ethyl)piperidine (5.3k). Prepared according to the general 
procedure in 55% yield as light yellow oil.  1H NMR (300 MHz, CDCl3) δ 7.24 – 7.17 
(m, 2H), 6.89 – 6.80 (m, 2H), 3.80 (s, 3H), 3.38 (q, J = 6.8 Hz, 1H), 2.43 – 2.28 (m, 4H), 
1.61 – 1.48 (m, 4H), 1.43 – 1.32 (m, 2H), 1.36 (d, J = 6.8 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 158.5, 135.7, 128.9, 113.4, 64.6, 55.3, 51.5, 26.3, 24.7, 19.4. HRMS (ESI, 
m/z): [M]+ calc.: 220.1701; found: 220.1711. 
 
 
1-(1-(2-methoxyphenyl)ethyl)piperidine (5.3l). Prepared according to the general 
procedure in 24% yield as light yellow oil.  1H NMR (300 MHz, CDCl3) δ 7.42 (dd, J = 
7.6, 1.8 Hz, 1H), 7.19 (ddt, J = 9.0, 7.1, 3.5 Hz, 1H), 6.94 (td, J = 7.5, 1.2 Hz, 1H), 6.86 
(d, J = 8.1 Hz, 1H), 3.97 (q, J = 6.8 Hz, 1H), 3.81 (s, 3H), 2.52 – 2.28 (m, 4H), 1.61 – 
1.50 (m, 4H), 1.43 – 1.34 (m, 2H), 1.31 (d, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δ 157.2, 132.3, 128.1, 127.4, 120.6, 110.7, 56.4, 55.6, 51.7, 26.4, 24.8, 19.8. HRMS 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Note:  Due to the lack of reaching synthetically useful yields, characterization was 
determined off of 1H NMR comparing to the spectra obtained from the crystal structure. 
 In an effort to determine if the low yields during optimization were substrate 
specific, a range of nitrones and acetylenes were tested with 3 equivalencies of nitrone to 
1 equivalent of acetylene at 60 oC (Table C-1).  Nitrone 2.7g was typically used due to 
its stability as compared to the other nitrones in optimization efforts.  When 2.7g or 2.7a 
were reacted with 3.11a, yields of 35% and 34% (Table C-1, entries 1 and 2) were 
obtained.  Similarly, when 2.7i or 2.7a were reacted with 3.11e, yields of 28% and 29% 
(Table C-1, entries 7 and 6) were obtained.  These preliminary results suggest that  
 
 
Entry R R’ PG % Yield 
1 2’-Me 2.7g i-Pr 3.11a Boc 3.9a 35% 
2 H 2.7a i-Pr 3.11a Boc 3.9b 34% 
3 2’-Me 2.7g i-Pr 3.11b Ac 3.9c 29% 
4 2’-Me 2.7g i-Pr 3.11c Ts 3.9d 27% 
5 2’-Me 2.7g i-Pr 3.11d COCF3 3.9e 23% 
6 H 2.7a Me 3.11e Boc 3.9f 29% 
7 3’-Me 2.7i Me 3.11e Boc 3.9g 28% 
8 H 2.7a Isobutyl 3.11f Boc 3.9h 43% 
9 H 2.7a H 3.11g Boc 3.9i 25% 
Table C-1 Scope of pyrroloindoline 3.9 
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substitution on the phenyl ring of the nitrone plays an insignificant role in the reaction.  
The acetylene seems to play an important role.  The protecting group also seems to have 
an impact.  Acetylenes 3.11a and 3.11b yielded similar results with a slight decrease 
with the use of 3.11b (35% and 29% yield, Table C-1, entries 1 and 3).  The tosyl and 
trifluoroacetyl protecting groups resulted in more complex reactions with approximate 
yields of 27% and 23% (Table C-1, entries 4 and 5).  The larger the R group in 3.11, the 
higher the yield.  As R increased from hydrogen (3.11g) to a methyl (3.11e) to iso-
propyl (3.11a) to isobutyl (3.11f), the respective yields increased from 25% to 29% to 
34% and to 43% (Table C-1, entries 9, 6, 2, and 8).   
 
Spectral data for compounds 
 Note:  spectra typically contain degradation products believed to originate from 
the indolenine formation.  As such, full characterization was not always performed since 




tetrahydropyrrolo[2,3-b]indole-1(2H)-carboxylate (3.9a). Yield = 35%.   1H NMR 
(300 MHz, CDCl3) δ 6.98 (dd, J = 7.5, 2.2 Hz, 2H), 6.71 (t, J = 7.5 Hz, 1H), 5.83 (s, 
1H), 5.41 (s, 1H), 3.80 (d, J = 3.3 Hz, 1H), 2.47 – 2.17 (m, 4H), 2.14 (s, 3H), 2.02 (s, 
 275 
 
3H), 2.00 - 1.91 (m, 1H), 1.60 (s, 3H), 1.44 (s, 6H), 1.09 (d, J = 7.0 Hz, 3H), 0.91 (d, J = 




tetrahydropyrrolo[2,3-b]indole-1(2H)-carboxylate (3.9b).  Yield = 34%.  1H NMR 
(300 MHz, CDCl3) δ 7.13 (d, J = 7.4 Hz, 2H), 6.77 (t, J = 7.5 Hz, 1H), 6.66 (d, J = 7.8 
Hz, 1H), 5.90 (s, 1H), 5.39 (s, 1H), 3.82 (d, J = 3.4 Hz, 1H), 2.43 – 2.20 (m, 4H), 2.02 
(s, 3H), 1.99 – 1.90 (m, 1H), 1.44 (s, 9H), 1.10 (d, J = 7.1 Hz, 3H), 0.90 (d, J = 7.0 Hz, 




tetrahydropyrrolo[2,3-b]indol-3(3aH)-one (3.9c). Yield = 29%.  1H NMR (300 MHz, 
CDCl3) δ 7.01 – 6.94 (m, 2H), 6.70 (t, J = 7.5 Hz, 1H), 5.94 (s, 1H), 5.56 (s, 1H), 3.86 
(d, J = 3.7 Hz, 1H), 2.37 – 2.23 (m, 4H), 2.12 (s, 3H), 2.03 (s, 3H), 2.01 (s, 3H), 1.17 (d, 





tetrahydropyrrolo[2,3-b]indole-1(2H)-carboxylate (3.9f).  Yield = 29%.  1H NMR 
(300 MHz, CDCl3) δ 7.18 – 7.09 (m, 2H), 6.76 (t, J = 7.5 Hz, 1H), 6.65 (d, J = 7.7 Hz, 
1H), 5.64 (s, 1H), 5.46 (s, 1H), 3.90 (q, J = 6.8Hz, 1H), 2.43 – 2.20 (m, 4H), 2.06 (s, 





tetrahydropyrrolo[2,3-b]indole-1(2H)-carboxylate (3.9g).  Yield = 28%.  1H NMR 
(300 MHz, CDCl3) δ 7.00 (d, J = 7.7 Hz, 1H), 6.59 (d, J = 7.7 Hz, 1H), 6.49 (s, 1H), 
5.58 (s, 1H), 5.44 (s, 1H), 3.91 (q, J = 7.2 Hz, 1H), 2.43 – 2.16 (m, 4H), 2.27 (s, 3H), 






tetrahydropyrrolo[2,3-b]indole-1(2H)-carboxylate (3.9h).  Yield = 43%.  1H NMR 
(300 MHz, CDCl3) δ 7.17 – 7.10 (m, 2H), 6.77 (t, J = 7.5 Hz, 1H), 6.66 (d, J = 7.9 Hz, 
1H), 5.77 (s, 1H), 5.40 (s, 1H), 3.95 – 3.84 (m, 1H), 2.44 – 2.20 (m, 4H), 2.04 (s, 3H), 




b]indole-1(2H)-carboxylate (3.9i).  Yield = 25%.  1H NMR (300 MHz,CDCl3) δ 7.19 – 7.03 
(m, 2H), 6.76 (t, J = 7.1 Hz, 1H), 6.66 (d, J = 7.8 Hz, 1H), 5.50 (s, 1H), 3.87 – 3.73 (m, 2H), 2.40 – 2.20 
(m, 3H), 2.17 – 2.09 (m, 1H), 2.05 (s, 3H), 1.47 (s, 9H). 
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